EP1509302A1 - Feste mykotoxinträger - Google Patents
Feste mykotoxinträgerInfo
- Publication number
- EP1509302A1 EP1509302A1 EP03755958A EP03755958A EP1509302A1 EP 1509302 A1 EP1509302 A1 EP 1509302A1 EP 03755958 A EP03755958 A EP 03755958A EP 03755958 A EP03755958 A EP 03755958A EP 1509302 A1 EP1509302 A1 EP 1509302A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- vinyl
- methyl
- acid
- ethyl
- mycotoxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000007787 solid Substances 0.000 title claims abstract description 8
- 239000000969 carrier Substances 0.000 title description 3
- 229920000642 polymer Polymers 0.000 claims abstract description 149
- 239000002636 mycotoxin Substances 0.000 claims abstract description 86
- 231100000678 Mycotoxin Toxicity 0.000 claims abstract description 85
- 238000000034 method Methods 0.000 claims abstract description 76
- 230000027455 binding Effects 0.000 claims abstract description 60
- 239000000243 solution Substances 0.000 claims abstract description 23
- 239000000725 suspension Substances 0.000 claims abstract description 19
- 239000000443 aerosol Substances 0.000 claims abstract description 12
- 239000000178 monomer Substances 0.000 claims description 80
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 73
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 claims description 57
- 229930002954 deoxynivalenol Natural products 0.000 claims description 57
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 claims description 57
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 51
- MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 claims description 46
- MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 claims description 46
- -1 deacetylcalonectrin Chemical compound 0.000 claims description 45
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 29
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical class C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 claims description 27
- 229920002554 vinyl polymer Polymers 0.000 claims description 27
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims description 26
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 24
- ITCSWEBPTQLQKN-UHFFFAOYSA-N Nivalenol Natural products CC1=CC2OC3C(O)C(O)C(C2(CO)CC1=O)C34CO4 ITCSWEBPTQLQKN-UHFFFAOYSA-N 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 22
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 18
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 claims description 16
- 239000004971 Cross linker Substances 0.000 claims description 15
- FPQFYIAXQDXNOR-QDKLYSGJSA-N alpha-Zearalenol Chemical compound O=C1O[C@@H](C)CCC[C@H](O)CCC\C=C\C2=CC(O)=CC(O)=C21 FPQFYIAXQDXNOR-QDKLYSGJSA-N 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 15
- VLSRKCIBHNJFHA-UHFFFAOYSA-N 2-(trifluoromethyl)prop-2-enoic acid Chemical class OC(=O)C(=C)C(F)(F)F VLSRKCIBHNJFHA-UHFFFAOYSA-N 0.000 claims description 14
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 229930195730 Aflatoxin Natural products 0.000 claims description 12
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 claims description 12
- XGCUCFKWVIWWNW-UHFFFAOYSA-N Fusarenone X Natural products CC(=O)OC1C(O)C2OC3C=C(C)C(=O)C(O)C3(CO)C1(C)C21CO1 XGCUCFKWVIWWNW-UHFFFAOYSA-N 0.000 claims description 12
- 239000005409 aflatoxin Substances 0.000 claims description 12
- MKUWVMRNQOOSAT-UHFFFAOYSA-N but-3-en-2-ol Chemical compound CC(O)C=C MKUWVMRNQOOSAT-UHFFFAOYSA-N 0.000 claims description 12
- XGCUCFKWVIWWNW-CAYGJDLQSA-N fusarenone x Chemical compound C([C@@]12[C@@]3(C)[C@@]4(CO)[C@H](O)C(=O)C(C)=C[C@H]4O[C@@H]1[C@H](O)[C@H]3OC(=O)C)O2 XGCUCFKWVIWWNW-CAYGJDLQSA-N 0.000 claims description 12
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 claims description 11
- UKOTXHQERFPCBU-YQPARWETSA-N Nivalenol Chemical compound C([C@]12[C@@]3([C@H](O)[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 UKOTXHQERFPCBU-YQPARWETSA-N 0.000 claims description 11
- 229920001577 copolymer Polymers 0.000 claims description 11
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 11
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims description 10
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 10
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 9
- IGDIDZAQDRAJRB-UPGMHYFXSA-N calonectrin Chemical compound C([C@@]12[C@]3(C)C[C@H]([C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)C)OC(C)=O)O2 IGDIDZAQDRAJRB-UPGMHYFXSA-N 0.000 claims description 9
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 claims description 8
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 claims description 8
- XWJBRBSPAODJER-UHFFFAOYSA-N 1,7-octadiene Chemical compound C=CCCCCC=C XWJBRBSPAODJER-UHFFFAOYSA-N 0.000 claims description 8
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 claims description 8
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N 1-Heptene Chemical compound CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 claims description 8
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 claims description 8
- CRSBERNSMYQZNG-UHFFFAOYSA-N 1-dodecene Chemical compound CCCCCCCCCCC=C CRSBERNSMYQZNG-UHFFFAOYSA-N 0.000 claims description 8
- UKDKWYQGLUUPBF-UHFFFAOYSA-N 1-ethenoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOC=C UKDKWYQGLUUPBF-UHFFFAOYSA-N 0.000 claims description 8
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims description 8
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 claims description 8
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 claims description 8
- PJLHTVIBELQURV-UHFFFAOYSA-N 1-pentadecene Chemical compound CCCCCCCCCCCCCC=C PJLHTVIBELQURV-UHFFFAOYSA-N 0.000 claims description 8
- JLIDVCMBCGBIEY-UHFFFAOYSA-N 1-penten-3-one Chemical compound CCC(=O)C=C JLIDVCMBCGBIEY-UHFFFAOYSA-N 0.000 claims description 8
- DCTOHCCUXLBQMS-UHFFFAOYSA-N 1-undecene Chemical compound CCCCCCCCCC=C DCTOHCCUXLBQMS-UHFFFAOYSA-N 0.000 claims description 8
- GFZMFCVDDFHSJK-UHFFFAOYSA-N 2-(methylideneamino)acetonitrile Chemical compound C=NCC#N GFZMFCVDDFHSJK-UHFFFAOYSA-N 0.000 claims description 8
- YOWQWFMSQCOSBA-UHFFFAOYSA-N 2-methoxypropene Chemical compound COC(C)=C YOWQWFMSQCOSBA-UHFFFAOYSA-N 0.000 claims description 8
- WWUVJRULCWHUSA-UHFFFAOYSA-N 2MP Natural products CCCC(C)=C WWUVJRULCWHUSA-UHFFFAOYSA-N 0.000 claims description 8
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 claims description 8
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 claims description 8
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 8
- KRCZYMFUWVJCLI-UHFFFAOYSA-N Dihydrocarveol Chemical compound CC1CCC(C(C)=C)CC1O KRCZYMFUWVJCLI-UHFFFAOYSA-N 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims description 8
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 8
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 8
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 claims description 8
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical compound CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 8
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 8
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims description 8
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims description 8
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims description 8
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims description 8
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 claims description 8
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 claims description 8
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 8
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 8
- VJHGSLHHMIELQD-UHFFFAOYSA-N nona-1,8-diene Chemical compound C=CCCCCCC=C VJHGSLHHMIELQD-UHFFFAOYSA-N 0.000 claims description 8
- NHLUYCJZUXOUBX-UHFFFAOYSA-N nonadec-1-ene Chemical compound CCCCCCCCCCCCCCCCCC=C NHLUYCJZUXOUBX-UHFFFAOYSA-N 0.000 claims description 8
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadec-1-ene Chemical compound CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 8
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 claims description 8
- 229940095574 propionic acid Drugs 0.000 claims description 8
- 239000003053 toxin Substances 0.000 claims description 8
- 231100000765 toxin Toxicity 0.000 claims description 8
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 claims description 8
- 229940117958 vinyl acetate Drugs 0.000 claims description 8
- BXFOFFBJRFZBQZ-QYWOHJEZSA-N T-2 toxin Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 BXFOFFBJRFZBQZ-QYWOHJEZSA-N 0.000 claims description 7
- VRAYVWUMBAJVGH-UHFFFAOYSA-M ethenyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C=C)C1=CC=CC=C1 VRAYVWUMBAJVGH-UHFFFAOYSA-M 0.000 claims description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 235000013373 food additive Nutrition 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 6
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims description 6
- MHNNAWXXUZQSNM-UHFFFAOYSA-N methylethylethylene Natural products CCC(C)=C MHNNAWXXUZQSNM-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 239000012454 non-polar solvent Substances 0.000 claims description 6
- 229920001567 vinyl ester resin Polymers 0.000 claims description 6
- 229960000834 vinyl ether Drugs 0.000 claims description 6
- 229960002300 zeranol Drugs 0.000 claims description 6
- ISRGONDNXBCDBM-UHFFFAOYSA-N 2-chlorostyrene Chemical compound ClC1=CC=CC=C1C=C ISRGONDNXBCDBM-UHFFFAOYSA-N 0.000 claims description 5
- YYPNJNDODFVZLE-UHFFFAOYSA-N 3-methylbut-2-enoic acid Chemical compound CC(C)=CC(O)=O YYPNJNDODFVZLE-UHFFFAOYSA-N 0.000 claims description 5
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 5
- PNKLMTPXERFKEN-MLXHEQMXSA-N HT-2 toxin Chemical compound C([C@@]12[C@]3(C)[C@H](O)[C@@H](O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 PNKLMTPXERFKEN-MLXHEQMXSA-N 0.000 claims description 5
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 claims description 5
- 230000007613 environmental effect Effects 0.000 claims description 5
- HCDGVLDPFQMKDK-UHFFFAOYSA-N hexafluoropropylene Chemical compound FC(F)=C(F)C(F)(F)F HCDGVLDPFQMKDK-UHFFFAOYSA-N 0.000 claims description 5
- 230000000977 initiatory effect Effects 0.000 claims description 5
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 5
- AZOCECCLWFDTAP-RKDXNWHRSA-N (+)-dihydrocarvone Chemical compound C[C@@H]1CC[C@@H](C(C)=C)CC1=O AZOCECCLWFDTAP-RKDXNWHRSA-N 0.000 claims description 4
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 claims description 4
- KMTSLOIAULARKN-OJVARPOJSA-N (1R,2R,7R,9R,10R,12S)-10-hydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-one Chemical compound CC1=C[C@H]2O[C@@H]3[C@H](O)C[C@@](C)([C@]33CO3)[C@@]2(CO)CC1=O KMTSLOIAULARKN-OJVARPOJSA-N 0.000 claims description 4
- PXEBOIUZEXXBGH-HRJXPNSYSA-N (1S,2R,7R,9R,10R,11S,12S)-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-10,11-diol Chemical compound C([C@@]12[C@@]3([C@H](O)[C@@H](O)[C@H]1O[C@@H]1C=C(CC[C@@]13CO)C)C)O2 PXEBOIUZEXXBGH-HRJXPNSYSA-N 0.000 claims description 4
- YTHRBOFHFYZBRJ-UHFFFAOYSA-N (2-methyl-5-prop-1-en-2-yl-1-cyclohex-2-enyl) acetate Chemical compound CC(=O)OC1CC(C(C)=C)CC=C1C YTHRBOFHFYZBRJ-UHFFFAOYSA-N 0.000 claims description 4
- MIHSPYMZXYONJN-RMKNXTFCSA-N (2e)-2,4-dimethylhepta-2,6-dienal Chemical compound C=CCC(C)\C=C(/C)C=O MIHSPYMZXYONJN-RMKNXTFCSA-N 0.000 claims description 4
- AXQVDJJOWPBMKM-XPPQAKCPSA-N (3S,9R,10S,13R,14R,17R)-14-hydroxy-13-methyl-17-(6-oxopyran-3-yl)-3-[(2S,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthrene-10-carbaldehyde Chemical compound C[C@]12CC[C@@H]3C(=CC=C4C[C@H](CC[C@]34C=O)O[C@@H]3OC[C@@H](O)[C@@H](O)[C@@H]3O)[C@@]1(O)CC[C@@H]2c1ccc(=O)oc1 AXQVDJJOWPBMKM-XPPQAKCPSA-N 0.000 claims description 4
- JAMNSIXSLVPNLC-UHFFFAOYSA-N (4-ethenylphenyl) acetate Chemical compound CC(=O)OC1=CC=C(C=C)C=C1 JAMNSIXSLVPNLC-UHFFFAOYSA-N 0.000 claims description 4
- GGGYNDMJSLHHEM-KKUMJFAQSA-N (4S)-4-[(1R,2S)-2-hydroxy-1,4-dimethylcyclohex-3-en-1-yl]-3-(hydroxymethyl)-4-methylcyclopent-2-en-1-one Chemical compound C1CC(C)=C[C@H](O)[C@@]1(C)[C@]1(C)C(CO)=CC(=O)C1 GGGYNDMJSLHHEM-KKUMJFAQSA-N 0.000 claims description 4
- HHLIJJJAKAFXJB-ONEGZZNKSA-N (4e)-hepta-4,6-dienoic acid Chemical compound OC(=O)CC\C=C\C=C HHLIJJJAKAFXJB-ONEGZZNKSA-N 0.000 claims description 4
- PRBHEGAFLDMLAL-GQCTYLIASA-N (4e)-hexa-1,4-diene Chemical compound C\C=C\CC=C PRBHEGAFLDMLAL-GQCTYLIASA-N 0.000 claims description 4
- FPANWDWGPATUTH-ULMRJCCDSA-N (7r)-4-[(1s)-4-hydroxy-1,4-dimethylcyclohex-2-en-1-yl]-4-methyl-1-oxaspiro[2.4]heptane-6,7-diol Chemical compound C12([C@H](O)C(O)CC2(C)[C@]2(C)C=CC(C)(O)CC2)CO1 FPANWDWGPATUTH-ULMRJCCDSA-N 0.000 claims description 4
- AFVDZBIIBXWASR-AATRIKPKSA-N (E)-1,3,5-hexatriene Chemical compound C=C\C=C\C=C AFVDZBIIBXWASR-AATRIKPKSA-N 0.000 claims description 4
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 claims description 4
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 claims description 4
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 4
- UWTUEMKLYAGTNQ-OWOJBTEDSA-N (e)-1,2-dibromoethene Chemical group Br\C=C\Br UWTUEMKLYAGTNQ-OWOJBTEDSA-N 0.000 claims description 4
- UBOXGVDOUJQMTN-UHFFFAOYSA-N 1,1,2-trichloroethane Chemical compound ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 claims description 4
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 claims description 4
- LGXVIGDEPROXKC-UHFFFAOYSA-N 1,1-dichloroethene Chemical compound ClC(Cl)=C LGXVIGDEPROXKC-UHFFFAOYSA-N 0.000 claims description 4
- ZAIDIVBQUMFXEC-UHFFFAOYSA-N 1,1-dichloroprop-1-ene Chemical compound CC=C(Cl)Cl ZAIDIVBQUMFXEC-UHFFFAOYSA-N 0.000 claims description 4
- YJCVRMIJBXTMNR-UHFFFAOYSA-N 1,3-dichloro-2-ethenylbenzene Chemical compound ClC1=CC=CC(Cl)=C1C=C YJCVRMIJBXTMNR-UHFFFAOYSA-N 0.000 claims description 4
- HMDQPBSDHHTRNI-UHFFFAOYSA-N 1-(chloromethyl)-3-ethenylbenzene Chemical compound ClCC1=CC=CC(C=C)=C1 HMDQPBSDHHTRNI-UHFFFAOYSA-N 0.000 claims description 4
- ZNRFPPAXFPJZRQ-UHFFFAOYSA-N 1-bromo-1,1-difluoropropane Chemical compound CCC(F)(F)Br ZNRFPPAXFPJZRQ-UHFFFAOYSA-N 0.000 claims description 4
- AYCANDRGVPTASA-UHFFFAOYSA-N 1-bromo-1,2,2-trifluoroethene Chemical group FC(F)=C(F)Br AYCANDRGVPTASA-UHFFFAOYSA-N 0.000 claims description 4
- WGGLDBIZIQMEGH-UHFFFAOYSA-N 1-bromo-4-ethenylbenzene Chemical compound BrC1=CC=C(C=C)C=C1 WGGLDBIZIQMEGH-UHFFFAOYSA-N 0.000 claims description 4
- BOVQCIDBZXNFEJ-UHFFFAOYSA-N 1-chloro-3-ethenylbenzene Chemical compound ClC1=CC=CC(C=C)=C1 BOVQCIDBZXNFEJ-UHFFFAOYSA-N 0.000 claims description 4
- KTZVZZJJVJQZHV-UHFFFAOYSA-N 1-chloro-4-ethenylbenzene Chemical compound ClC1=CC=C(C=C)C=C1 KTZVZZJJVJQZHV-UHFFFAOYSA-N 0.000 claims description 4
- LFSHREXVLSTLFB-UHFFFAOYSA-N 1-cyanoethenyl acetate Chemical compound CC(=O)OC(=C)C#N LFSHREXVLSTLFB-UHFFFAOYSA-N 0.000 claims description 4
- MEHLEOUIWVWVBF-UHFFFAOYSA-N 1-cyanoprop-2-enyl acetate Chemical compound CC(=O)OC(C=C)C#N MEHLEOUIWVWVBF-UHFFFAOYSA-N 0.000 claims description 4
- GXZPMXGRNUXGHN-UHFFFAOYSA-N 1-ethenoxy-2-methoxyethane Chemical compound COCCOC=C GXZPMXGRNUXGHN-UHFFFAOYSA-N 0.000 claims description 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 4
- OEVVKKAVYQFQNV-UHFFFAOYSA-N 1-ethenyl-2,4-dimethylbenzene Chemical compound CC1=CC=C(C=C)C(C)=C1 OEVVKKAVYQFQNV-UHFFFAOYSA-N 0.000 claims description 4
- YNQXOOPPJWSXMW-UHFFFAOYSA-N 1-ethenyl-2-fluorobenzene Chemical compound FC1=CC=CC=C1C=C YNQXOOPPJWSXMW-UHFFFAOYSA-N 0.000 claims description 4
- NVZWEEGUWXZOKI-UHFFFAOYSA-N 1-ethenyl-2-methylbenzene Chemical compound CC1=CC=CC=C1C=C NVZWEEGUWXZOKI-UHFFFAOYSA-N 0.000 claims description 4
- LFICVUCVPKKPFF-UHFFFAOYSA-N 1-ethenyl-3,5-bis(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC(C=C)=CC(C(F)(F)F)=C1 LFICVUCVPKKPFF-UHFFFAOYSA-N 0.000 claims description 4
- ZJSKEGAHBAHFON-UHFFFAOYSA-N 1-ethenyl-3-fluorobenzene Chemical compound FC1=CC=CC(C=C)=C1 ZJSKEGAHBAHFON-UHFFFAOYSA-N 0.000 claims description 4
- JZHGRUMIRATHIU-UHFFFAOYSA-N 1-ethenyl-3-methylbenzene Chemical compound CC1=CC=CC(C=C)=C1 JZHGRUMIRATHIU-UHFFFAOYSA-N 0.000 claims description 4
- SYZVQXIUVGKCBJ-UHFFFAOYSA-N 1-ethenyl-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(C=C)=C1 SYZVQXIUVGKCBJ-UHFFFAOYSA-N 0.000 claims description 4
- JWVTWJNGILGLAT-UHFFFAOYSA-N 1-ethenyl-4-fluorobenzene Chemical compound FC1=CC=C(C=C)C=C1 JWVTWJNGILGLAT-UHFFFAOYSA-N 0.000 claims description 4
- UAJRSHJHFRVGMG-UHFFFAOYSA-N 1-ethenyl-4-methoxybenzene Chemical compound COC1=CC=C(C=C)C=C1 UAJRSHJHFRVGMG-UHFFFAOYSA-N 0.000 claims description 4
- BJEWLOAZFAGNPE-UHFFFAOYSA-N 1-ethenylsulfonylethane Chemical compound CCS(=O)(=O)C=C BJEWLOAZFAGNPE-UHFFFAOYSA-N 0.000 claims description 4
- DKZRLCHWDNEKRH-UHFFFAOYSA-N 1-nonoxynonane Chemical compound CCCCCCCCCOCCCCCCCCC DKZRLCHWDNEKRH-UHFFFAOYSA-N 0.000 claims description 4
- MHHJQVRGRPHIMR-UHFFFAOYSA-N 1-phenylprop-2-en-1-ol Chemical compound C=CC(O)C1=CC=CC=C1 MHHJQVRGRPHIMR-UHFFFAOYSA-N 0.000 claims description 4
- WAUKBOOEPYNAGU-UHFFFAOYSA-N 1-phenylprop-2-enyl acetate Chemical compound CC(=O)OC(C=C)C1=CC=CC=C1 WAUKBOOEPYNAGU-UHFFFAOYSA-N 0.000 claims description 4
- DGPVNNMFVYYVDF-UHFFFAOYSA-N 1-prop-2-enoylpyrrolidin-2-one Chemical compound C=CC(=O)N1CCCC1=O DGPVNNMFVYYVDF-UHFFFAOYSA-N 0.000 claims description 4
- DXSDIWHOOOBQTJ-UHFFFAOYSA-N 2,2-dimethylpent-4-enal Chemical compound O=CC(C)(C)CC=C DXSDIWHOOOBQTJ-UHFFFAOYSA-N 0.000 claims description 4
- FALCMQXTWHPRIH-UHFFFAOYSA-N 2,3-dichloroprop-1-ene Chemical compound ClCC(Cl)=C FALCMQXTWHPRIH-UHFFFAOYSA-N 0.000 claims description 4
- OWWIWYDDISJUMY-UHFFFAOYSA-N 2,3-dimethylbut-1-ene Chemical compound CC(C)C(C)=C OWWIWYDDISJUMY-UHFFFAOYSA-N 0.000 claims description 4
- CCTFAOUOYLVUFG-UHFFFAOYSA-N 2-(1-amino-1-imino-2-methylpropan-2-yl)azo-2-methylpropanimidamide Chemical compound NC(=N)C(C)(C)N=NC(C)(C)C(N)=N CCTFAOUOYLVUFG-UHFFFAOYSA-N 0.000 claims description 4
- UDCLFLLKQIRWHA-UHFFFAOYSA-N 2-(2,4-dichloro-5-fluorophenyl)-2-oxoacetaldehyde Chemical compound FC1=CC(C(=O)C=O)=C(Cl)C=C1Cl UDCLFLLKQIRWHA-UHFFFAOYSA-N 0.000 claims description 4
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 claims description 4
- IBDVWXAVKPRHCU-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCCOC(=O)C(C)=C IBDVWXAVKPRHCU-UHFFFAOYSA-N 0.000 claims description 4
- NIRGKKDBRNHLTN-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)propan-2-yl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)OC(=O)C(C)=C NIRGKKDBRNHLTN-UHFFFAOYSA-N 0.000 claims description 4
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 4
- XEZCCHVCBAZAQD-UHFFFAOYSA-N 2-(aziridin-1-yl)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCN1CC1 XEZCCHVCBAZAQD-UHFFFAOYSA-N 0.000 claims description 4
- CQXWCEVXNRHUSQ-UHFFFAOYSA-N 2-(chloromethyl)prop-2-enyl-trimethylsilane Chemical compound C[Si](C)(C)CC(=C)CCl CQXWCEVXNRHUSQ-UHFFFAOYSA-N 0.000 claims description 4
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims description 4
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 4
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 claims description 4
- UFDFFEMHDKXMBG-UHFFFAOYSA-N 2-acetamidoprop-2-enoic acid Chemical compound CC(=O)NC(=C)C(O)=O UFDFFEMHDKXMBG-UHFFFAOYSA-N 0.000 claims description 4
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 claims description 4
- HMENQNSSJFLQOP-UHFFFAOYSA-N 2-bromoprop-2-enoic acid Chemical compound OC(=O)C(Br)=C HMENQNSSJFLQOP-UHFFFAOYSA-N 0.000 claims description 4
- OYUNTGBISCIYPW-UHFFFAOYSA-N 2-chloroprop-2-enenitrile Chemical compound ClC(=C)C#N OYUNTGBISCIYPW-UHFFFAOYSA-N 0.000 claims description 4
- PDELBHCVXBSVPJ-UHFFFAOYSA-N 2-ethenyl-1,3,5-trimethylbenzene Chemical group CC1=CC(C)=C(C=C)C(C)=C1 PDELBHCVXBSVPJ-UHFFFAOYSA-N 0.000 claims description 4
- SFHOANYKPCNYMB-UHFFFAOYSA-N 2-ethenyl-1,3-difluorobenzene Chemical compound FC1=CC=CC(F)=C1C=C SFHOANYKPCNYMB-UHFFFAOYSA-N 0.000 claims description 4
- DBWWINQJTZYDFK-UHFFFAOYSA-N 2-ethenyl-1,4-dimethylbenzene Chemical compound CC1=CC=C(C)C(C=C)=C1 DBWWINQJTZYDFK-UHFFFAOYSA-N 0.000 claims description 4
- FVCDMHWSPLRYAB-UHFFFAOYSA-N 2-ethenyl-2-methyloxirane Chemical compound C=CC1(C)CO1 FVCDMHWSPLRYAB-UHFFFAOYSA-N 0.000 claims description 4
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 claims description 4
- NEYTXADIGVEHQD-UHFFFAOYSA-N 2-hydroxy-2-(prop-2-enoylamino)acetic acid Chemical compound OC(=O)C(O)NC(=O)C=C NEYTXADIGVEHQD-UHFFFAOYSA-N 0.000 claims description 4
- BOFLDKIFLIFLJA-UHFFFAOYSA-N 2-methylbut-1-en-3-yne Chemical compound CC(=C)C#C BOFLDKIFLIFLJA-UHFFFAOYSA-N 0.000 claims description 4
- IRUDSQHLKGNCGF-UHFFFAOYSA-N 2-methylhex-1-ene Chemical compound CCCCC(C)=C IRUDSQHLKGNCGF-UHFFFAOYSA-N 0.000 claims description 4
- GMLDCZYTIPCVMO-UHFFFAOYSA-N 2-methylidenebutanal Chemical compound CCC(=C)C=O GMLDCZYTIPCVMO-UHFFFAOYSA-N 0.000 claims description 4
- IWEWQGKFUYQGSN-UHFFFAOYSA-N 2-methylidenehexanal Chemical compound CCCCC(=C)C=O IWEWQGKFUYQGSN-UHFFFAOYSA-N 0.000 claims description 4
- NGCJVMZXRCLPRQ-UHFFFAOYSA-N 2-methylidenepentanedinitrile Chemical compound N#CC(=C)CCC#N NGCJVMZXRCLPRQ-UHFFFAOYSA-N 0.000 claims description 4
- JFFYKITVXPZLQS-UHFFFAOYSA-N 2-methylidenepropane-1,3-diol Chemical compound OCC(=C)CO JFFYKITVXPZLQS-UHFFFAOYSA-N 0.000 claims description 4
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 claims description 4
- ONWRSBMOCIQLRK-UHFFFAOYSA-N 2-phenylethenesulfonyl chloride Chemical compound ClS(=O)(=O)C=CC1=CC=CC=C1 ONWRSBMOCIQLRK-UHFFFAOYSA-N 0.000 claims description 4
- HEDYZFYQYPWWCC-UHFFFAOYSA-N 2-prop-1-en-2-ylaniline Chemical compound CC(=C)C1=CC=CC=C1N HEDYZFYQYPWWCC-UHFFFAOYSA-N 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- KXYAVSFOJVUIHT-UHFFFAOYSA-N 2-vinylnaphthalene Chemical compound C1=CC=CC2=CC(C=C)=CC=C21 KXYAVSFOJVUIHT-UHFFFAOYSA-N 0.000 claims description 4
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 claims description 4
- FVUXHXRZJMFQJL-UHFFFAOYSA-N 3'-Hydroxy-T2-triol Chemical compound OCC12CC(OC(=O)CC(C)(C)O)C(C)=CC1OC1C(O)C(O)C2(C)C11CO1 FVUXHXRZJMFQJL-UHFFFAOYSA-N 0.000 claims description 4
- VJOAJCOCCYFXPR-UHFFFAOYSA-N 3,3,3-trifluoro-2-methylprop-1-ene Chemical compound CC(=C)C(F)(F)F VJOAJCOCCYFXPR-UHFFFAOYSA-N 0.000 claims description 4
- OBWGMYALGNDUNM-UHFFFAOYSA-N 3,3-dimethoxyprop-1-ene Chemical compound COC(OC)C=C OBWGMYALGNDUNM-UHFFFAOYSA-N 0.000 claims description 4
- PKXHXOTZMFCXSH-UHFFFAOYSA-N 3,3-dimethylbut-1-ene Chemical compound CC(C)(C)C=C PKXHXOTZMFCXSH-UHFFFAOYSA-N 0.000 claims description 4
- DSSAWHFZNWVJEC-UHFFFAOYSA-N 3-(ethenoxymethyl)heptane Chemical compound CCCCC(CC)COC=C DSSAWHFZNWVJEC-UHFFFAOYSA-N 0.000 claims description 4
- OHXAOPZTJOUYKM-UHFFFAOYSA-N 3-Chloro-2-methylpropene Chemical compound CC(=C)CCl OHXAOPZTJOUYKM-UHFFFAOYSA-N 0.000 claims description 4
- REEBWSYYNPPSKV-UHFFFAOYSA-N 3-[(4-formylphenoxy)methyl]thiophene-2-carbonitrile Chemical compound C1=CC(C=O)=CC=C1OCC1=C(C#N)SC=C1 REEBWSYYNPPSKV-UHFFFAOYSA-N 0.000 claims description 4
- JBTDFRNUVWFUGL-UHFFFAOYSA-N 3-aminopropyl carbamimidothioate;dihydrobromide Chemical compound Br.Br.NCCCSC(N)=N JBTDFRNUVWFUGL-UHFFFAOYSA-N 0.000 claims description 4
- XJFZOSUFGSANIF-UHFFFAOYSA-N 3-chloro-2-(chloromethyl)prop-1-ene Chemical compound ClCC(=C)CCl XJFZOSUFGSANIF-UHFFFAOYSA-N 0.000 claims description 4
- VZGLVCFVUREVDP-UHFFFAOYSA-N 3-chlorobut-1-ene Chemical compound CC(Cl)C=C VZGLVCFVUREVDP-UHFFFAOYSA-N 0.000 claims description 4
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical compound ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 claims description 4
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 claims description 4
- QVDTXNVYSHVCGW-UHFFFAOYSA-N 3-methylbut-1-en-1-ol Chemical compound CC(C)C=CO QVDTXNVYSHVCGW-UHFFFAOYSA-N 0.000 claims description 4
- YHQXBTXEYZIYOV-UHFFFAOYSA-N 3-methylbut-1-ene Chemical compound CC(C)C=C YHQXBTXEYZIYOV-UHFFFAOYSA-N 0.000 claims description 4
- SEPQTYODOKLVSB-UHFFFAOYSA-N 3-methylbut-2-enal Chemical compound CC(C)=CC=O SEPQTYODOKLVSB-UHFFFAOYSA-N 0.000 claims description 4
- BDUBTLFQHNYXPC-UHFFFAOYSA-N 3-methylbut-2-enoyl chloride Chemical compound CC(C)=CC(Cl)=O BDUBTLFQHNYXPC-UHFFFAOYSA-N 0.000 claims description 4
- ULYIFEQRRINMJQ-UHFFFAOYSA-N 3-methylbutyl 2-methylprop-2-enoate Chemical compound CC(C)CCOC(=O)C(C)=C ULYIFEQRRINMJQ-UHFFFAOYSA-N 0.000 claims description 4
- RYKZRKKEYSRDNF-UHFFFAOYSA-N 3-methylidenepentane Chemical compound CCC(=C)CC RYKZRKKEYSRDNF-UHFFFAOYSA-N 0.000 claims description 4
- LDTAOIUHUHHCMU-UHFFFAOYSA-N 3-methylpent-1-ene Chemical compound CCC(C)C=C LDTAOIUHUHHCMU-UHFFFAOYSA-N 0.000 claims description 4
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 claims description 4
- VFXXTYGQYWRHJP-UHFFFAOYSA-N 4,4'-azobis(4-cyanopentanoic acid) Chemical compound OC(=O)CCC(C)(C#N)N=NC(C)(CCC(O)=O)C#N VFXXTYGQYWRHJP-UHFFFAOYSA-N 0.000 claims description 4
- BBDKZWKEPDTENS-UHFFFAOYSA-N 4-Vinylcyclohexene Chemical compound C=CC1CCC=CC1 BBDKZWKEPDTENS-UHFFFAOYSA-N 0.000 claims description 4
- DMAYBPBPEUFIHJ-UHFFFAOYSA-N 4-bromobut-1-ene Chemical compound BrCCC=C DMAYBPBPEUFIHJ-UHFFFAOYSA-N 0.000 claims description 4
- PMZXJPLGCUVUDN-UHFFFAOYSA-N 4-ethenyl-1,2-dimethylbenzene Chemical compound CC1=CC=C(C=C)C=C1C PMZXJPLGCUVUDN-UHFFFAOYSA-N 0.000 claims description 4
- DPAUCHAAEWIRKG-UHFFFAOYSA-N 4-ethenyl-2-methoxy-1-phenylmethoxybenzene Chemical compound COC1=CC(C=C)=CC=C1OCC1=CC=CC=C1 DPAUCHAAEWIRKG-UHFFFAOYSA-N 0.000 claims description 4
- HHSVPRXLNYVHLR-UHFFFAOYSA-N 4-propanoyl HT-2 Natural products CCC(=O)OC1C(O)C2OC3C=C(C)C(OC(=O)CC(C)C)CC3(COC(C)=O)C1(C)C21CO1 HHSVPRXLNYVHLR-UHFFFAOYSA-N 0.000 claims description 4
- OECTYKWYRCHAKR-UHFFFAOYSA-N 4-vinylcyclohexene dioxide Chemical compound C1OC1C1CC2OC2CC1 OECTYKWYRCHAKR-UHFFFAOYSA-N 0.000 claims description 4
- NNWNNQTUZYVQRK-UHFFFAOYSA-N 5-bromo-1h-pyrrolo[2,3-c]pyridine-2-carboxylic acid Chemical compound BrC1=NC=C2NC(C(=O)O)=CC2=C1 NNWNNQTUZYVQRK-UHFFFAOYSA-N 0.000 claims description 4
- LPNANKDXVBMDKE-UHFFFAOYSA-N 5-bromopent-1-ene Chemical compound BrCCCC=C LPNANKDXVBMDKE-UHFFFAOYSA-N 0.000 claims description 4
- JETUZEFHWCTPQD-UHFFFAOYSA-N 5-ethenyl-4,6,11-trioxa-1-aza-5-silabicyclo[3.3.3]undecane Chemical compound O1CCN2CCO[Si]1(C=C)OCC2 JETUZEFHWCTPQD-UHFFFAOYSA-N 0.000 claims description 4
- INYHZQLKOKTDAI-UHFFFAOYSA-N 5-ethenylbicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(C=C)CC1C=C2 INYHZQLKOKTDAI-UHFFFAOYSA-N 0.000 claims description 4
- RIMXEJYJXDBLIE-UHFFFAOYSA-N 6-bromohex-1-ene Chemical compound BrCCCCC=C RIMXEJYJXDBLIE-UHFFFAOYSA-N 0.000 claims description 4
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 claims description 4
- YFFFUAJRMITKHA-UHFFFAOYSA-N 7-hydroxyisotrichodermin Chemical compound CC(=O)OC1CC2OC3C=C(C)CC(O)C3(C)C1(C)C21CO1 YFFFUAJRMITKHA-UHFFFAOYSA-N 0.000 claims description 4
- SNMOMUYLFLGQQS-UHFFFAOYSA-N 8-bromooct-1-ene Chemical compound BrCCCCCCC=C SNMOMUYLFLGQQS-UHFFFAOYSA-N 0.000 claims description 4
- HIFINEVHSHYJHR-YDFGWWAZSA-N 8-hydroxy-2-[(1e,3e)-4-(8-hydroxy-5-methyl-7-oxo-3,4-dihydro-2h-cyclohepta[b]pyran-2-yl)buta-1,3-dienyl]-3,5-dimethyl-3,4-dihydro-2h-cyclohepta[b]pyran-7-one Chemical compound C1CC(C(=CC(=O)C(O)=C2)C)=C2OC1/C=C/C=C/C1OC(C=C(O)C(=O)C=C2C)=C2CC1C HIFINEVHSHYJHR-YDFGWWAZSA-N 0.000 claims description 4
- CTKOKSZTCSYSMC-UHFFFAOYSA-N 8-methoxy-3-(1-phenylethyl)-2,4-dihydro-1,3-benzoxazine Chemical compound C1OC=2C(OC)=CC=CC=2CN1C(C)C1=CC=CC=C1 CTKOKSZTCSYSMC-UHFFFAOYSA-N 0.000 claims description 4
- OGOYZCQQQFAGRI-UHFFFAOYSA-N 9-ethenylanthracene Chemical compound C1=CC=C2C(C=C)=C(C=CC=C3)C3=CC2=C1 OGOYZCQQQFAGRI-UHFFFAOYSA-N 0.000 claims description 4
- FPANWDWGPATUTH-UHFFFAOYSA-N 9alpha-hydroxytrichotriol Natural products C1CC(C)(O)C=CC1(C)C1(C)CC(O)C(O)C11CO1 FPANWDWGPATUTH-UHFFFAOYSA-N 0.000 claims description 4
- 229930132918 Aflatoxin B2 Natural products 0.000 claims description 4
- WPCVRWVBBXIRMA-WNWIJWBNSA-N Aflatoxin G2 Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1[C@@H]1CCO[C@@H]1O2 WPCVRWVBBXIRMA-WNWIJWBNSA-N 0.000 claims description 4
- 229930166256 Aflatoxin G2 Natural products 0.000 claims description 4
- 229930088287 Aflatoxin M2 Natural products 0.000 claims description 4
- OQLKWHFMUPJCJY-UHFFFAOYSA-N Aflatoxin M2 Chemical compound C1=2C(OC)=CC=3OC4OCCC4(O)C=3C=2OC(=O)C2=C1CCC2=O OQLKWHFMUPJCJY-UHFFFAOYSA-N 0.000 claims description 4
- XTEPTFLIHDCWDH-UHFFFAOYSA-N C1=CC(C=C)=CC=C1C1=CC=CC=C1.C1=CC(C=C)=CC=C1C1=CC=CC=C1 Chemical compound C1=CC(C=C)=CC=C1C1=CC=CC=C1.C1=CC(C=C)=CC=C1C1=CC=CC=C1 XTEPTFLIHDCWDH-UHFFFAOYSA-N 0.000 claims description 4
- HIBWGGKDGCBPTA-UHFFFAOYSA-N C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 HIBWGGKDGCBPTA-UHFFFAOYSA-N 0.000 claims description 4
- 229920002574 CR-39 Polymers 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 4
- UCNVFOCBFJOQAL-UHFFFAOYSA-N DDE Chemical group C=1C=C(Cl)C=CC=1C(=C(Cl)Cl)C1=CC=C(Cl)C=C1 UCNVFOCBFJOQAL-UHFFFAOYSA-N 0.000 claims description 4
- TUSIZTVSUSBSQI-UHFFFAOYSA-N Dihydrocarveol acetate Chemical compound CC1CCC(C(C)=C)CC1OC(C)=O TUSIZTVSUSBSQI-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- GXBYFVGCMPJVJX-UHFFFAOYSA-N Epoxybutene Chemical compound C=CC1CO1 GXBYFVGCMPJVJX-UHFFFAOYSA-N 0.000 claims description 4
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 4
- UXDPXZQHTDAXOZ-UHFFFAOYSA-N Fumonisin B2 Natural products OC(=O)CC(C(O)=O)CC(=O)OC(C(C)CCCC)C(OC(=O)CC(CC(O)=O)C(O)=O)CC(C)CCCCCCC(O)CC(O)C(C)N UXDPXZQHTDAXOZ-UHFFFAOYSA-N 0.000 claims description 4
- CPCRJSQNWHCGOP-KUHXKYQKSA-N Fumonisin B3 Chemical compound OC(=O)CC(C(O)=O)CC(=O)O[C@H]([C@H](C)CCCC)[C@@H](OC(=O)CC(CC(O)=O)C(O)=O)C[C@@H](C)C[C@H](O)CCCCCC[C@@H](O)[C@H](C)N CPCRJSQNWHCGOP-KUHXKYQKSA-N 0.000 claims description 4
- FZFYFSUIOSWLHW-UNZVFGKVSA-N Fusarin C Chemical compound N([C@@]1(CCO)O)C(=O)[C@]2(C(=O)C(/C)=C/C=C/C(/C)=C/C(/C)=C/C(=C\C)/C(=O)OC)[C@H]1O2 FZFYFSUIOSWLHW-UNZVFGKVSA-N 0.000 claims description 4
- HIFINEVHSHYJHR-UHFFFAOYSA-N Fusariocin C Natural products C1CC(C(=CC(=O)C(O)=C2)C)=C2OC1C=CC=CC1OC(C=C(O)C(=O)C=C2C)=C2CC1C HIFINEVHSHYJHR-UHFFFAOYSA-N 0.000 claims description 4
- OZXJPPYWZVBMGW-UHFFFAOYSA-N Isotrichodermin Natural products C1=C(C)CCC2(C)C1OC1C(OC(=O)C)CC2(C)C21CO2 OZXJPPYWZVBMGW-UHFFFAOYSA-N 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- STNJBCKSHOAVAJ-UHFFFAOYSA-N Methacrolein Chemical compound CC(=C)C=O STNJBCKSHOAVAJ-UHFFFAOYSA-N 0.000 claims description 4
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims description 4
- TVZHDVCTOCZDNE-UHFFFAOYSA-N Neosolaniol Natural products CC(=O)OCC12CC(O)C(C)=CC1OC1C(O)C(OC(C)=O)C2(C)C11CO1 TVZHDVCTOCZDNE-UHFFFAOYSA-N 0.000 claims description 4
- PIHGROVBUUNPDW-UHFFFAOYSA-N Nivalenol-diacetat Natural products CC(=O)OCC12C(O)C(=O)C(C)=CC1OC1C(O)C(OC(C)=O)C2(C)C11CO1 PIHGROVBUUNPDW-UHFFFAOYSA-N 0.000 claims description 4
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 claims description 4
- GMPDOIGGGXSAPL-UHFFFAOYSA-N Phenyl vinyl sulfide Natural products C=CSC1=CC=CC=C1 GMPDOIGGGXSAPL-UHFFFAOYSA-N 0.000 claims description 4
- RCFUVEKOPPKTBN-HSZRPRSMSA-N Sporotrichiol Chemical compound C([C@@]12[C@]3(C)C[C@@H](O)[C@H]1O[C@H]1[C@]3(CO)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 RCFUVEKOPPKTBN-HSZRPRSMSA-N 0.000 claims description 4
- RCFUVEKOPPKTBN-UHFFFAOYSA-N Sporotrichiol Natural products C1=C(C)C(OC(=O)CC(C)C)CC2(CO)C1OC1C(O)CC2(C)C11CO1 RCFUVEKOPPKTBN-UHFFFAOYSA-N 0.000 claims description 4
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 claims description 4
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 4
- APJDQUGPCJRQRJ-UHFFFAOYSA-N Zearalanone Natural products O=C1OC(C)CCCC(=O)CCCCCC2=CC(O)=CC(O)=C21 APJDQUGPCJRQRJ-UHFFFAOYSA-N 0.000 claims description 4
- OMBCNOXJYCTBAT-RBSDREOVSA-N [(1R,2R,4S,7R,9R,10R,12S)-10-acetyloxy-4-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate Chemical compound CC(=O)OC[C@]12C[C@H](O)C(C)=C[C@H]1O[C@@H]1[C@@H](C[C@@]2(C)[C@]11CO1)OC(C)=O OMBCNOXJYCTBAT-RBSDREOVSA-N 0.000 claims description 4
- NOZAQBYNLKNDRT-UHFFFAOYSA-N [diacetyloxy(ethenyl)silyl] acetate Chemical compound CC(=O)O[Si](OC(C)=O)(OC(C)=O)C=C NOZAQBYNLKNDRT-UHFFFAOYSA-N 0.000 claims description 4
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002097 aflatoxin B2 Substances 0.000 claims description 4
- WWSYXEZEXMQWHT-WNWIJWBNSA-N aflatoxin B2 Chemical compound C=1([C@@H]2CCO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O WWSYXEZEXMQWHT-WNWIJWBNSA-N 0.000 claims description 4
- 239000002100 aflatoxin G2 Substances 0.000 claims description 4
- 239000002087 aflatoxin M2 Substances 0.000 claims description 4
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 4
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 claims description 4
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 claims description 4
- INLLPKCGLOXCIV-UHFFFAOYSA-N bromoethene Chemical compound BrC=C INLLPKCGLOXCIV-UHFFFAOYSA-N 0.000 claims description 4
- RODCZGBQVPTRTI-UHFFFAOYSA-N but-1-en-2-yl(tributyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C(=C)CC RODCZGBQVPTRTI-UHFFFAOYSA-N 0.000 claims description 4
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 claims description 4
- PBGVMIDTGGTBFS-UHFFFAOYSA-N but-3-enylbenzene Chemical compound C=CCCC1=CC=CC=C1 PBGVMIDTGGTBFS-UHFFFAOYSA-N 0.000 claims description 4
- ZNFCVBVACPUQLW-UHFFFAOYSA-N buta-1,3-diene iron Chemical compound [Fe].C=CC=C ZNFCVBVACPUQLW-UHFFFAOYSA-N 0.000 claims description 4
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Natural products CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims description 4
- ZAXZBJSXSOISTF-LYFQSNBGSA-N chembl152377 Chemical compound C([C@@]12[C@@]3([C@H](O)[C@@H](O)[C@H]1O[C@@H]1C=C([C@H](C[C@@]13CO)O)C)C)O2 ZAXZBJSXSOISTF-LYFQSNBGSA-N 0.000 claims description 4
- XSDCTSITJJJDPY-UHFFFAOYSA-N chloro-ethenyl-dimethylsilane Chemical compound C[Si](C)(Cl)C=C XSDCTSITJJJDPY-UHFFFAOYSA-N 0.000 claims description 4
- MHMUCYJKZUZMNJ-UPHRSURJSA-N cis-3-chloroacrylic acid Chemical compound OC(=O)\C=C/Cl MHMUCYJKZUZMNJ-UPHRSURJSA-N 0.000 claims description 4
- NLDGJRWPPOSWLC-UHFFFAOYSA-N deca-1,9-diene Chemical compound C=CCCCCCCC=C NLDGJRWPPOSWLC-UHFFFAOYSA-N 0.000 claims description 4
- PIHGROVBUUNPDW-SUWHGTQISA-N diacetylnivalenol Chemical compound CC1([C@H](OC(C)=O)[C@@H](O)[C@H]2O[C@@H]3C=C(C)C(=O)[C@@H](O)[C@@]31COC(=O)C)C21CO1 PIHGROVBUUNPDW-SUWHGTQISA-N 0.000 claims description 4
- LWHKXKZPLXYXRO-UHFFFAOYSA-L dichloro-bis(ethenyl)stannane Chemical compound C=C[Sn](Cl)(Cl)C=C LWHKXKZPLXYXRO-UHFFFAOYSA-L 0.000 claims description 4
- YLJJAVFOBDSYAN-UHFFFAOYSA-N dichloro-ethenyl-methylsilane Chemical compound C[Si](Cl)(Cl)C=C YLJJAVFOBDSYAN-UHFFFAOYSA-N 0.000 claims description 4
- QDGONURINHVBEW-UHFFFAOYSA-N dichlorodifluoroethylene Chemical group FC(F)=C(Cl)Cl QDGONURINHVBEW-UHFFFAOYSA-N 0.000 claims description 4
- 229930007024 dihydrocarveol Natural products 0.000 claims description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N dimethylmethane Natural products CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 4
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 4
- 229940069096 dodecene Drugs 0.000 claims description 4
- FZFYFSUIOSWLHW-WWNPGLIZSA-N epi-fusarin C Natural products COC(=O)C(=CC)C=C(/C)C=C(/C)C=CC=C(/C)C(=O)[C@]12O[C@H]1[C@](O)(CCO)NC2=O FZFYFSUIOSWLHW-WWNPGLIZSA-N 0.000 claims description 4
- 125000003700 epoxy group Chemical group 0.000 claims description 4
- ZBGRMWIREQJHPK-UHFFFAOYSA-N ethenyl 2,2,2-trifluoroacetate Chemical compound FC(F)(F)C(=O)OC=C ZBGRMWIREQJHPK-UHFFFAOYSA-N 0.000 claims description 4
- XJELOQYISYPGDX-UHFFFAOYSA-N ethenyl 2-chloroacetate Chemical compound ClCC(=O)OC=C XJELOQYISYPGDX-UHFFFAOYSA-N 0.000 claims description 4
- IGBZOHMCHDADGY-UHFFFAOYSA-N ethenyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OC=C IGBZOHMCHDADGY-UHFFFAOYSA-N 0.000 claims description 4
- GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 claims description 4
- GFJVXXWOPWLRNU-UHFFFAOYSA-N ethenyl formate Chemical compound C=COC=O GFJVXXWOPWLRNU-UHFFFAOYSA-N 0.000 claims description 4
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 claims description 4
- AJVBXLXLODZUME-UHFFFAOYSA-N ethenyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=C)C1=CC=CC=C1 AJVBXLXLODZUME-UHFFFAOYSA-N 0.000 claims description 4
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 claims description 4
- HBWGDHDXAMFADB-UHFFFAOYSA-N ethenyl(triethyl)silane Chemical compound CC[Si](CC)(CC)C=C HBWGDHDXAMFADB-UHFFFAOYSA-N 0.000 claims description 4
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 claims description 4
- GCSJLQSCSDMKTP-UHFFFAOYSA-N ethenyl(trimethyl)silane Chemical compound C[Si](C)(C)C=C GCSJLQSCSDMKTP-UHFFFAOYSA-N 0.000 claims description 4
- JEWCZPTVOYXPGG-UHFFFAOYSA-N ethenyl-ethoxy-dimethylsilane Chemical compound CCO[Si](C)(C)C=C JEWCZPTVOYXPGG-UHFFFAOYSA-N 0.000 claims description 4
- WOXXJEVNDJOOLV-UHFFFAOYSA-N ethenyl-tris(2-methoxyethoxy)silane Chemical compound COCCO[Si](OCCOC)(OCCOC)C=C WOXXJEVNDJOOLV-UHFFFAOYSA-N 0.000 claims description 4
- LDLDYFCCDKENPD-UHFFFAOYSA-N ethenylcyclohexane Chemical compound C=CC1CCCCC1 LDLDYFCCDKENPD-UHFFFAOYSA-N 0.000 claims description 4
- MZMJHXFYLRTLQX-UHFFFAOYSA-N ethenylsulfinylbenzene Chemical compound C=CS(=O)C1=CC=CC=C1 MZMJHXFYLRTLQX-UHFFFAOYSA-N 0.000 claims description 4
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 4
- 239000003008 fumonisin Substances 0.000 claims description 4
- UXDPXZQHTDAXOZ-STOIETHLSA-N fumonisin B2 Chemical compound OC(=O)C[C@@H](C(O)=O)CC(=O)O[C@H]([C@H](C)CCCC)[C@@H](OC(=O)C[C@@H](CC(O)=O)C(O)=O)C[C@@H](C)CCCCCC[C@@H](O)C[C@H](O)[C@H](C)N UXDPXZQHTDAXOZ-STOIETHLSA-N 0.000 claims description 4
- CPCRJSQNWHCGOP-UHFFFAOYSA-N fumonisin B3 Natural products OC(=O)CC(C(O)=O)CC(=O)OC(C(C)CCCC)C(OC(=O)CC(CC(O)=O)C(O)=O)CC(C)CC(O)CCCCCCC(O)C(C)N CPCRJSQNWHCGOP-UHFFFAOYSA-N 0.000 claims description 4
- UTGFOWQYZKTZTN-UHFFFAOYSA-N hepta-1,6-dien-4-ol Chemical compound C=CCC(O)CC=C UTGFOWQYZKTZTN-UHFFFAOYSA-N 0.000 claims description 4
- PBZROIMXDZTJDF-UHFFFAOYSA-N hepta-1,6-dien-4-one Chemical compound C=CCC(=O)CC=C PBZROIMXDZTJDF-UHFFFAOYSA-N 0.000 claims description 4
- GEAWFZNTIFJMHR-UHFFFAOYSA-N hepta-1,6-diene Chemical compound C=CCCCC=C GEAWFZNTIFJMHR-UHFFFAOYSA-N 0.000 claims description 4
- UIZVMOZAXAMASY-UHFFFAOYSA-N hex-5-en-1-ol Chemical compound OCCCCC=C UIZVMOZAXAMASY-UHFFFAOYSA-N 0.000 claims description 4
- SZYLTIUVWARXOO-UHFFFAOYSA-N hexa-1,5-dien-3-ol Chemical compound C=CC(O)CC=C SZYLTIUVWARXOO-UHFFFAOYSA-N 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- GHXZPUGJZVBLGC-UHFFFAOYSA-N iodoethene Chemical compound IC=C GHXZPUGJZVBLGC-UHFFFAOYSA-N 0.000 claims description 4
- 239000012948 isocyanate Substances 0.000 claims description 4
- 229940095045 isopulegol Drugs 0.000 claims description 4
- OZXJPPYWZVBMGW-IKIFYQGPSA-N isotrichodermin Chemical compound CC(=O)O[C@@H]1C[C@@]2(C)[C@]3(CO3)[C@@H]1O[C@@H]1C=C(C)CC[C@]21C OZXJPPYWZVBMGW-IKIFYQGPSA-N 0.000 claims description 4
- BSLBENVVENBYIW-UHFFFAOYSA-L lead(2+);prop-2-enoate Chemical compound [Pb+2].[O-]C(=O)C=C.[O-]C(=O)C=C BSLBENVVENBYIW-UHFFFAOYSA-L 0.000 claims description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 4
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 claims description 4
- RMGJCSHZTFKPNO-UHFFFAOYSA-M magnesium;ethene;bromide Chemical compound [Mg+2].[Br-].[CH-]=C RMGJCSHZTFKPNO-UHFFFAOYSA-M 0.000 claims description 4
- 125000005395 methacrylic acid group Chemical class 0.000 claims description 4
- DCUFMVPCXCSVNP-UHFFFAOYSA-N methacrylic anhydride Chemical compound CC(=C)C(=O)OC(=O)C(C)=C DCUFMVPCXCSVNP-UHFFFAOYSA-N 0.000 claims description 4
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 claims description 4
- CFTUQSLVERGMHL-UHFFFAOYSA-N methyl 2-(bromomethyl)prop-2-enoate Chemical compound COC(=O)C(=C)CBr CFTUQSLVERGMHL-UHFFFAOYSA-N 0.000 claims description 4
- IHBKAGRPNRKYAO-UHFFFAOYSA-M methyl sulfate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound COS([O-])(=O)=O.CC(=C)C(=O)OCC[N+](C)(C)C IHBKAGRPNRKYAO-UHFFFAOYSA-M 0.000 claims description 4
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 claims description 4
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 4
- WFKDPJRCBCBQNT-UHFFFAOYSA-N n,2-dimethylprop-2-enamide Chemical compound CNC(=O)C(C)=C WFKDPJRCBCBQNT-UHFFFAOYSA-N 0.000 claims description 4
- GUAQVFRUPZBRJQ-UHFFFAOYSA-N n-(3-aminopropyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCCCN GUAQVFRUPZBRJQ-UHFFFAOYSA-N 0.000 claims description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 4
- MVBJSQCJPSRKSW-UHFFFAOYSA-N n-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]prop-2-enamide Chemical compound OCC(CO)(CO)NC(=O)C=C MVBJSQCJPSRKSW-UHFFFAOYSA-N 0.000 claims description 4
- XFHJDMUEHUHAJW-UHFFFAOYSA-N n-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 claims description 4
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 claims description 4
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 claims description 4
- TVZHDVCTOCZDNE-WVJYZQHISA-N neosolaniol Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@@H]1C=C(C)[C@@H](O)C[C@@]13COC(=O)C)O2 TVZHDVCTOCZDNE-WVJYZQHISA-N 0.000 claims description 4
- CSYVMZMEBKUDRQ-BNWDXEGFSA-N nt-2 toxin Chemical compound C([C@@]12[C@@]3(C)[C@@]4(CO)C[C@H](O)C(C)=C[C@H]4O[C@@H]1[C@H](O)[C@H]3OC(=O)C)O2 CSYVMZMEBKUDRQ-BNWDXEGFSA-N 0.000 claims description 4
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 claims description 4
- ZHZCYWWNFQUZOR-UHFFFAOYSA-N pent-4-en-2-ol Chemical compound CC(O)CC=C ZHZCYWWNFQUZOR-UHFFFAOYSA-N 0.000 claims description 4
- HVAMZGADVCBITI-UHFFFAOYSA-N pent-4-enoic acid Chemical compound OC(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-N 0.000 claims description 4
- ICMWSAALRSINTC-UHFFFAOYSA-N penta-1,4-dien-3-ol Chemical compound C=CC(O)C=C ICMWSAALRSINTC-UHFFFAOYSA-N 0.000 claims description 4
- QYZLKGVUSQXAMU-UHFFFAOYSA-N penta-1,4-diene Chemical compound C=CCC=C QYZLKGVUSQXAMU-UHFFFAOYSA-N 0.000 claims description 4
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 4
- CILDJVVXNMDAGY-UHFFFAOYSA-N phenyl ethenesulfonate Chemical compound C=CS(=O)(=O)OC1=CC=CC=C1 CILDJVVXNMDAGY-UHFFFAOYSA-N 0.000 claims description 4
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 claims description 4
- VSFOXJWBPGONDR-UHFFFAOYSA-M potassium;3-prop-2-enoyloxypropane-1-sulfonate Chemical compound [K+].[O-]S(=O)(=O)CCCOC(=O)C=C VSFOXJWBPGONDR-UHFFFAOYSA-M 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- AMMGCGVWJMRTQI-UHFFFAOYSA-N prop-1-en-2-yl carbonochloridate Chemical compound CC(=C)OC(Cl)=O AMMGCGVWJMRTQI-UHFFFAOYSA-N 0.000 claims description 4
- 239000001294 propane Substances 0.000 claims description 4
- PXEBOIUZEXXBGH-UHFFFAOYSA-N scirpenetriol Natural products OCC12CCC(C)=CC1OC1C(O)C(O)C2(C)C11CO1 PXEBOIUZEXXBGH-UHFFFAOYSA-N 0.000 claims description 4
- 238000005549 size reduction Methods 0.000 claims description 4
- QGRSLAYMCFPMHW-UHFFFAOYSA-M sodium;3-(2-methylprop-2-enoyloxy)propane-1-sulfonate Chemical compound [Na+].CC(=C)C(=O)OCCCS([O-])(=O)=O QGRSLAYMCFPMHW-UHFFFAOYSA-M 0.000 claims description 4
- XFTALRAZSCGSKN-UHFFFAOYSA-M sodium;4-ethenylbenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=C(C=C)C=C1 XFTALRAZSCGSKN-UHFFFAOYSA-M 0.000 claims description 4
- BWYYYTVSBPRQCN-UHFFFAOYSA-M sodium;ethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=C BWYYYTVSBPRQCN-UHFFFAOYSA-M 0.000 claims description 4
- DIKJULDDNQFCJG-UHFFFAOYSA-M sodium;prop-2-ene-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC=C DIKJULDDNQFCJG-UHFFFAOYSA-M 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- NOTOVTQRFFVBSB-VZPCOZJFSA-N t-2 acetate Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 NOTOVTQRFFVBSB-VZPCOZJFSA-N 0.000 claims description 4
- UOORRWUZONOOLO-UHFFFAOYSA-N telone II Natural products ClCC=CCl UOORRWUZONOOLO-UHFFFAOYSA-N 0.000 claims description 4
- PQEXLIRUMIRSAL-UHFFFAOYSA-N tert-butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate Chemical compound CCOC(=O)CC1CCN(C(=O)OC(C)(C)C)CC1 PQEXLIRUMIRSAL-UHFFFAOYSA-N 0.000 claims description 4
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 claims description 4
- 229950011008 tetrachloroethylene Drugs 0.000 claims description 4
- NLDYACGHTUPAQU-UHFFFAOYSA-N tetracyanoethylene Chemical group N#CC(C#N)=C(C#N)C#N NLDYACGHTUPAQU-UHFFFAOYSA-N 0.000 claims description 4
- MHMUCYJKZUZMNJ-OWOJBTEDSA-N trans-3-chloroacrylic acid Chemical compound OC(=O)\C=C\Cl MHMUCYJKZUZMNJ-OWOJBTEDSA-N 0.000 claims description 4
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 claims description 4
- GQIUQDDJKHLHTB-UHFFFAOYSA-N trichloro(ethenyl)silane Chemical compound Cl[Si](Cl)(Cl)C=C GQIUQDDJKHLHTB-UHFFFAOYSA-N 0.000 claims description 4
- ZTONSNFKELYEEH-UHFFFAOYSA-N trichloro(ethenyl)silane 1,2,2-trichloroethenylsilane Chemical compound [SiH3]C(Cl)=C(Cl)Cl.Cl[Si](Cl)(Cl)C=C ZTONSNFKELYEEH-UHFFFAOYSA-N 0.000 claims description 4
- BEIXTGGJVNHLEO-UHFFFAOYSA-N trimethyl(3-trimethylsilyloxybuta-1,3-dien-2-yloxy)silane Chemical compound C[Si](C)(C)OC(=C)C(=C)O[Si](C)(C)C BEIXTGGJVNHLEO-UHFFFAOYSA-N 0.000 claims description 4
- UZNHKBFIBYXPDV-UHFFFAOYSA-N trimethyl-[3-(2-methylprop-2-enoylamino)propyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)NCCC[N+](C)(C)C UZNHKBFIBYXPDV-UHFFFAOYSA-N 0.000 claims description 4
- 229940070710 valerate Drugs 0.000 claims description 4
- YCJYNBLLJHFIIW-MBABXGOBSA-N validoxylamine A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)C[C@@H]1N[C@@H]1[C@H](O)[C@@H](O)[C@H](O)C(CO)=C1 YCJYNBLLJHFIIW-MBABXGOBSA-N 0.000 claims description 4
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 claims description 4
- 239000005050 vinyl trichlorosilane Substances 0.000 claims description 4
- ZTWTYVWXUKTLCP-UHFFFAOYSA-N vinylphosphonic acid Chemical compound OP(O)(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-N 0.000 claims description 4
- ISSYTHPTTMFJKL-UHFFFAOYSA-N 1-ethenylcyclopentene Chemical compound C=CC1=CCCC1 ISSYTHPTTMFJKL-UHFFFAOYSA-N 0.000 claims description 3
- WUIJTQZXUURFQU-UHFFFAOYSA-N 1-methylsulfonylethene Chemical compound CS(=O)(=O)C=C WUIJTQZXUURFQU-UHFFFAOYSA-N 0.000 claims description 3
- OOHZIRUJZFRULE-UHFFFAOYSA-N 2,2-dimethylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(C)(C)C OOHZIRUJZFRULE-UHFFFAOYSA-N 0.000 claims description 3
- QAFGEOHWEQLURJ-UHFFFAOYSA-N 2,4-diethylhepta-2,6-dienal Chemical compound C=CCC(CC)C=C(CC)C=O QAFGEOHWEQLURJ-UHFFFAOYSA-N 0.000 claims description 3
- YBRHBMHQQIEOOL-UHFFFAOYSA-N 2,4-dimethylhepta-2,6-dien-1-ol Chemical compound C=CCC(C)C=C(C)CO YBRHBMHQQIEOOL-UHFFFAOYSA-N 0.000 claims description 3
- NOOYFQLPKUQDNE-UHFFFAOYSA-N 2-(bromomethyl)prop-2-enoic acid Chemical compound OC(=O)C(=C)CBr NOOYFQLPKUQDNE-UHFFFAOYSA-N 0.000 claims description 3
- XUGNJOCQALIQFG-UHFFFAOYSA-N 2-ethenylquinoline Chemical compound C1=CC=CC2=NC(C=C)=CC=C21 XUGNJOCQALIQFG-UHFFFAOYSA-N 0.000 claims description 3
- RCBGGJURENJHKV-UHFFFAOYSA-N 2-methylhept-1-ene Chemical compound CCCCCC(C)=C RCBGGJURENJHKV-UHFFFAOYSA-N 0.000 claims description 3
- RANGFOQREJPKIH-UHFFFAOYSA-N 3,15-diacetyl deoxynivalenol Natural products CC(=O)OCC12C(O)C(=O)C(C)=CC1OC1C(OC(C)=O)CC2(C)C11CO1 RANGFOQREJPKIH-UHFFFAOYSA-N 0.000 claims description 3
- PRCYIYOCMALJCX-UHFFFAOYSA-N 4,4-diethoxybut-1-ene Chemical compound CCOC(CC=C)OCC PRCYIYOCMALJCX-UHFFFAOYSA-N 0.000 claims description 3
- VBCIOOKAKHGVMI-UHFFFAOYSA-N 5-methylhex-5-en-2-one Chemical compound CC(=C)CCC(C)=O VBCIOOKAKHGVMI-UHFFFAOYSA-N 0.000 claims description 3
- 239000004593 Epoxy Substances 0.000 claims description 3
- FQZWQQJWFJBXDG-UHFFFAOYSA-N N1C(C=C2C(=C(C=C)C(C=C3C(=C(C=C)C(=C4)N3)C)=N2)C)=C(C)C=C1C=C1C=C(C)C4=N1 Chemical compound N1C(C=C2C(=C(C=C)C(C=C3C(=C(C=C)C(=C4)N3)C)=N2)C)=C(C)C=C1C=C1C=C(C)C4=N1 FQZWQQJWFJBXDG-UHFFFAOYSA-N 0.000 claims description 3
- RANGFOQREJPKIH-CHPZEFIJSA-N [(1R,2R,3S,7R,9R,10R,12S)-10-acetyloxy-3-hydroxy-1,5-dimethyl-4-oxospiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate Chemical compound C([C@@]12[C@]3(C)C[C@H]([C@H]1O[C@@H]1C=C(C)C(=O)[C@@H](O)[C@@]13COC(=O)C)OC(C)=O)O2 RANGFOQREJPKIH-CHPZEFIJSA-N 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 3
- FSIJKGMIQTVTNP-UHFFFAOYSA-N bis(ethenyl)-methyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C=C)C=C FSIJKGMIQTVTNP-UHFFFAOYSA-N 0.000 claims description 3
- KLDLHTWQLPMOGM-UHFFFAOYSA-N but-3-enyl carbonochloridate Chemical compound ClC(=O)OCCC=C KLDLHTWQLPMOGM-UHFFFAOYSA-N 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate Chemical compound [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims description 3
- 229920000647 polyepoxide Polymers 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- 150000003673 urethanes Chemical class 0.000 claims description 3
- FQTLCLSUCSAZDY-SDNWHVSQSA-N (6E)-nerolidol Chemical compound CC(C)=CCC\C(C)=C\CCC(C)(O)C=C FQTLCLSUCSAZDY-SDNWHVSQSA-N 0.000 claims description 2
- MYWOJODOMFBVCB-UHFFFAOYSA-N 1,2,6-trimethylphenanthrene Chemical compound CC1=CC=C2C3=CC(C)=CC=C3C=CC2=C1C MYWOJODOMFBVCB-UHFFFAOYSA-N 0.000 claims description 2
- KOMNUTZXSVSERR-UHFFFAOYSA-N 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical compound C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O KOMNUTZXSVSERR-UHFFFAOYSA-N 0.000 claims description 2
- OGBWMWKMTUSNKE-UHFFFAOYSA-N 1-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CCCCCC(OC(=O)C(C)=C)OC(=O)C(C)=C OGBWMWKMTUSNKE-UHFFFAOYSA-N 0.000 claims description 2
- VOBUAPTXJKMNCT-UHFFFAOYSA-N 1-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound CCCCCC(OC(=O)C=C)OC(=O)C=C VOBUAPTXJKMNCT-UHFFFAOYSA-N 0.000 claims description 2
- LQJPFRZLZSLIIO-UHFFFAOYSA-N 2,11-dimethyldodeca-2,10-dienediamide Chemical compound NC(=O)C(C)=CCCCCCCC=C(C)C(N)=O LQJPFRZLZSLIIO-UHFFFAOYSA-N 0.000 claims description 2
- JFJRBHWEWMLWNL-UHFFFAOYSA-N 2,2-bis(ethenyl)propanedioic acid Chemical compound OC(=O)C(C=C)(C=C)C(O)=O JFJRBHWEWMLWNL-UHFFFAOYSA-N 0.000 claims description 2
- YEJMAZMIHIFTFO-UHFFFAOYSA-N 2-[2-(4-carbamimidoylphenyl)-3h-benzimidazol-5-yl]-3h-benzimidazole-5-carboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)C(N)=N)C=C2N1 YEJMAZMIHIFTFO-UHFFFAOYSA-N 0.000 claims description 2
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 claims description 2
- DPNXHTDWGGVXID-UHFFFAOYSA-N 2-isocyanatoethyl prop-2-enoate Chemical compound C=CC(=O)OCCN=C=O DPNXHTDWGGVXID-UHFFFAOYSA-N 0.000 claims description 2
- ORTCGSWQDZPULK-UHFFFAOYSA-N 3-isocyanatopropyl prop-2-enoate Chemical compound C=CC(=O)OCCCN=C=O ORTCGSWQDZPULK-UHFFFAOYSA-N 0.000 claims description 2
- 229920000877 Melamine resin Polymers 0.000 claims description 2
- BXFOFFBJRFZBQZ-UHFFFAOYSA-N T2 Toxin Natural products C1=C(C)C(OC(=O)CC(C)C)CC2(COC(C)=O)C1OC1C(O)C(OC(C)=O)C2(C)C11CO1 BXFOFFBJRFZBQZ-UHFFFAOYSA-N 0.000 claims description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
- 150000001336 alkenes Chemical class 0.000 claims description 2
- IHTWATXYZJSPOM-UHFFFAOYSA-N bis(ethenyl) oxalate Chemical compound C=COC(=O)C(=O)OC=C IHTWATXYZJSPOM-UHFFFAOYSA-N 0.000 claims description 2
- ZPOLOEWJWXZUSP-WAYWQWQTSA-N bis(prop-2-enyl) (z)-but-2-enedioate Chemical compound C=CCOC(=O)\C=C/C(=O)OCC=C ZPOLOEWJWXZUSP-WAYWQWQTSA-N 0.000 claims description 2
- HABAXTXIECRCKH-UHFFFAOYSA-N bis(prop-2-enyl) butanedioate Chemical compound C=CCOC(=O)CCC(=O)OCC=C HABAXTXIECRCKH-UHFFFAOYSA-N 0.000 claims description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 claims description 2
- 125000004386 diacrylate group Chemical group 0.000 claims description 2
- VVYDVQWJZWRVPE-UHFFFAOYSA-L dimethyltin(2+);diiodide Chemical compound C[Sn](C)(I)I VVYDVQWJZWRVPE-UHFFFAOYSA-L 0.000 claims description 2
- NVLHKSGUMYMKRR-UHFFFAOYSA-N dodeca-2,10-dienediamide Chemical compound NC(=O)C=CCCCCCCC=CC(N)=O NVLHKSGUMYMKRR-UHFFFAOYSA-N 0.000 claims description 2
- 239000008235 industrial water Substances 0.000 claims description 2
- 239000002207 metabolite Substances 0.000 claims description 2
- RBQRWNWVPQDTJJ-UHFFFAOYSA-N methacryloyloxyethyl isocyanate Chemical compound CC(=C)C(=O)OCCN=C=O RBQRWNWVPQDTJJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 2
- 238000003801 milling Methods 0.000 claims description 2
- 239000008237 rinsing water Substances 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- 239000002351 wastewater Substances 0.000 claims description 2
- JSKXQQKSUOVSKS-UHFFFAOYSA-N 7alpha,8alpha-Dihydroxycalonectrin Chemical compound CC(=O)OCC12C(O)C(O)C(C)=CC1OC1C(OC(C)=O)CC2(C)C11CO1 JSKXQQKSUOVSKS-UHFFFAOYSA-N 0.000 claims 2
- UVPSSGJTBLNVRE-UHFFFAOYSA-N Moniliformin Natural products O=C1C(OC)=CC(=O)C=2C1=C1C(=O)C(OC)=CC(=O)C1=CC=2 UVPSSGJTBLNVRE-UHFFFAOYSA-N 0.000 claims 2
- KGPQKNJSZNXOPV-UHFFFAOYSA-N moniliformin Chemical compound OC1=CC(=O)C1=O KGPQKNJSZNXOPV-UHFFFAOYSA-N 0.000 claims 2
- AFFPCIMDERUIST-UHFFFAOYSA-N trimethyl(1-phenylethenoxy)silane Chemical group C[Si](C)(C)OC(=C)C1=CC=CC=C1 AFFPCIMDERUIST-UHFFFAOYSA-N 0.000 claims 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N (2E,4E)-2,4-hexadienedioic acid Natural products OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 claims 1
- QAFGEOHWEQLURJ-DHZHZOJOSA-N (2e)-2,4-diethylhepta-2,6-dienal Chemical compound C=CCC(CC)\C=C(/CC)C=O QAFGEOHWEQLURJ-DHZHZOJOSA-N 0.000 claims 1
- YBRHBMHQQIEOOL-RMKNXTFCSA-N (2e)-2,4-dimethylhepta-2,6-dien-1-ol Chemical compound C=CCC(C)\C=C(/C)CO YBRHBMHQQIEOOL-RMKNXTFCSA-N 0.000 claims 1
- LXKRFDPUBWVICN-SNAWJCMRSA-N (5e)-2-methylhepta-1,5-diene Chemical compound C\C=C\CCC(C)=C LXKRFDPUBWVICN-SNAWJCMRSA-N 0.000 claims 1
- RCJMVGJKROQDCB-UHFFFAOYSA-N 1,3-dimethyl-1,3-butadiene Natural products CC=CC(C)=C RCJMVGJKROQDCB-UHFFFAOYSA-N 0.000 claims 1
- RNUBNNOJHWDSIX-UHFFFAOYSA-N 1-cyclopropylethenoxy(trimethyl)silane Chemical group C[Si](C)(C)OC(=C)C1CC1 RNUBNNOJHWDSIX-UHFFFAOYSA-N 0.000 claims 1
- DRWYRROCDFQZQF-UHFFFAOYSA-N 2-methylpenta-1,4-diene Chemical compound CC(=C)CC=C DRWYRROCDFQZQF-UHFFFAOYSA-N 0.000 claims 1
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- NMQQBXHZBNUXGJ-SNAWJCMRSA-N [(1e)-buta-1,3-dienyl] acetate Chemical compound CC(=O)O\C=C\C=C NMQQBXHZBNUXGJ-SNAWJCMRSA-N 0.000 claims 1
- YSVZGWAJIHWNQK-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]heptanyl]methanol Chemical compound C1CC2C(CO)C(CO)C1C2 YSVZGWAJIHWNQK-UHFFFAOYSA-N 0.000 claims 1
- OHNGJKYLXUCBBU-UHFFFAOYSA-N bis(ethenyl)-ethyl-triethylsilyloxysilane Chemical compound CC[Si](CC)(CC)O[Si](CC)(C=C)C=C OHNGJKYLXUCBBU-UHFFFAOYSA-N 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- KUQWZSZYIQGTHT-UHFFFAOYSA-N hexa-1,5-diene-3,4-diol Chemical compound C=CC(O)C(O)C=C KUQWZSZYIQGTHT-UHFFFAOYSA-N 0.000 claims 1
- TXXHDPDFNKHHGW-ZPUQHVIOSA-N trans,trans-muconic acid Chemical compound OC(=O)\C=C\C=C\C(O)=O TXXHDPDFNKHHGW-ZPUQHVIOSA-N 0.000 claims 1
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 56
- 239000012071 phase Substances 0.000 description 33
- 102100028748 Transportin-1 Human genes 0.000 description 29
- 238000004128 high performance liquid chromatography Methods 0.000 description 27
- 230000003993 interaction Effects 0.000 description 24
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 23
- 230000014759 maintenance of location Effects 0.000 description 23
- 239000000126 substance Substances 0.000 description 21
- 239000012491 analyte Substances 0.000 description 20
- 239000002245 particle Substances 0.000 description 19
- 238000000926 separation method Methods 0.000 description 18
- 239000001257 hydrogen Substances 0.000 description 17
- 229910052739 hydrogen Inorganic materials 0.000 description 17
- 238000013459 approach Methods 0.000 description 15
- 229960001285 quercetin Drugs 0.000 description 15
- 230000005526 G1 to G0 transition Effects 0.000 description 14
- 239000000758 substrate Substances 0.000 description 14
- ADFIQZBYNGPCGY-HTJQZXIKSA-N 3-acetyldeoxynivalenol Chemical compound C([C@]12[C@]3(C)C[C@H]([C@H]2O[C@H]2[C@@]3([C@H](O)C(=O)C(C)=C2)CO)OC(=O)C)O1 ADFIQZBYNGPCGY-HTJQZXIKSA-N 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000004132 cross linking Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 11
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 11
- 239000003361 porogen Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 235000005875 quercetin Nutrition 0.000 description 11
- 239000002594 sorbent Substances 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 125000000524 functional group Chemical group 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- IDGRYIRJIFKTAN-HTJQZXIKSA-N 15-acetyldeoxynivalenol Chemical compound C([C@@]12[C@]3(C)C[C@@H](O)[C@H]1O[C@@H]1C=C(C)C(=O)[C@@H](O)[C@@]13COC(=O)C)O2 IDGRYIRJIFKTAN-HTJQZXIKSA-N 0.000 description 7
- IDGRYIRJIFKTAN-UHFFFAOYSA-N 3-acetyldeoxynivalenol Natural products CC(=O)OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 IDGRYIRJIFKTAN-UHFFFAOYSA-N 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- 230000002860 competitive effect Effects 0.000 description 7
- 125000004122 cyclic group Chemical group 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- ADFIQZBYNGPCGY-UHFFFAOYSA-N Acetyldeoxynivalenol Natural products C1=C(C)C(=O)C(O)C2(CO)C1OC1C(OC(=O)C)CC2(C)C21CO2 ADFIQZBYNGPCGY-UHFFFAOYSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- PFNQVRZLDWYSCW-UHFFFAOYSA-N (fluoren-9-ylideneamino) n-naphthalen-1-ylcarbamate Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1=NOC(=O)NC1=CC=CC2=CC=CC=C12 PFNQVRZLDWYSCW-UHFFFAOYSA-N 0.000 description 5
- 239000012736 aqueous medium Substances 0.000 description 5
- 235000013405 beer Nutrition 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000001338 self-assembly Methods 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- RJYQLMILDVERHH-UHFFFAOYSA-N 4-Ipomeanol Chemical compound CC(O)CCC(=O)C=1C=COC=1 RJYQLMILDVERHH-UHFFFAOYSA-N 0.000 description 4
- 108010031480 Artificial Receptors Proteins 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000005202 decontamination Methods 0.000 description 4
- 230000003588 decontaminative effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000009881 electrostatic interaction Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 229940102838 methylmethacrylate Drugs 0.000 description 3
- RWQKHEORZBHNRI-BMIGLBTASA-N ochratoxin A Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 RWQKHEORZBHNRI-BMIGLBTASA-N 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 238000004454 trace mineral analysis Methods 0.000 description 3
- 229930013292 trichothecene Natural products 0.000 description 3
- LZAJKCZTKKKZNT-PMNGPLLRSA-N trichothecene Chemical compound C12([C@@]3(CC[C@H]2OC2C=C(CCC23C)C)C)CO1 LZAJKCZTKKKZNT-PMNGPLLRSA-N 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- GHTAWZGQTQGHOQ-NHYWBVRUSA-N (2s)-2-[[(3s)-5-chloro-8-hydroxy-3-(hydroxymethyl)-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)CO)C(O)=O)C1=CC=CC=C1 GHTAWZGQTQGHOQ-NHYWBVRUSA-N 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- KEOYKWIOAINZSQ-UHFFFAOYSA-N alpha-Zearalenol Natural products CC1CCCC(O)CCC=CCc2cc(O)cc(O)c2C(=O)O1 KEOYKWIOAINZSQ-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000012062 aqueous buffer Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- HFTNNOZFRQLFQB-UHFFFAOYSA-N ethenoxy(trimethyl)silane Chemical group C[Si](C)(C)OC=C HFTNNOZFRQLFQB-UHFFFAOYSA-N 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001597 immobilized metal affinity chromatography Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229930183344 ochratoxin Natural products 0.000 description 2
- DAEYIVCTQUFNTM-UHFFFAOYSA-N ochratoxin B Natural products OC1=C2C(=O)OC(C)CC2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 DAEYIVCTQUFNTM-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N phthalic acid di-n-butyl ester Natural products CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000003586 protic polar solvent Substances 0.000 description 2
- 238000003380 quartz crystal microbalance Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- DIRRKLFMHQUJCM-UHFFFAOYSA-N (2-aminophenyl)boronic acid Chemical compound NC1=CC=CC=C1B(O)O DIRRKLFMHQUJCM-UHFFFAOYSA-N 0.000 description 1
- POPKYYDFBOZZGX-RXMQYKEDSA-N (3r)-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carboxylic acid Chemical compound C1=C(C(O)=O)C(O)=C2C(=O)O[C@H](C)CC2=C1 POPKYYDFBOZZGX-RXMQYKEDSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- NVVDPSZOAIMZLZ-UHFFFAOYSA-N 5-(diethylamino)-2-methylpent-2-enoic acid Chemical compound CCN(CC)CCC=C(C)C(O)=O NVVDPSZOAIMZLZ-UHFFFAOYSA-N 0.000 description 1
- FPQFYIAXQDXNOR-UHFFFAOYSA-N 7beta-trans-zearalenol Natural products O=C1OC(C)CCCC(O)CCCC=CC2=CC(O)=CC(O)=C21 FPQFYIAXQDXNOR-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- MDTQMLVLPFHAFC-UHFFFAOYSA-N 8-hydroxyisotrichodermin Chemical compound CC(=O)OC1CC2OC3C=C(C)C(O)CC3(C)C1(C)C21CO1 MDTQMLVLPFHAFC-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- XZCFXOYULQTJQO-UHFFFAOYSA-N CCOC(CC=C)OCC.OC(=O)C=CC=CC(O)=O Chemical compound CCOC(CC=C)OCC.OC(=O)C=CC=CC(O)=O XZCFXOYULQTJQO-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- VYLQGYLYRQKMFU-UHFFFAOYSA-N Ochratoxin A Natural products CC1Cc2c(Cl)cc(CNC(Cc3ccccc3)C(=O)O)cc2C(=O)O1 VYLQGYLYRQKMFU-UHFFFAOYSA-N 0.000 description 1
- OSFWJKYWJMZKSM-UHFFFAOYSA-N Ochratoxin alpha Natural products C1=C(C(O)=O)C(O)=C2C(=O)OC(C)CC2=C1Cl OSFWJKYWJMZKSM-UHFFFAOYSA-N 0.000 description 1
- BPZZWRPHVVDAPT-UHFFFAOYSA-N Ochratoxin-A-ethylester Natural products C=1C(Cl)=C2CC(C)OC(=O)C2=C(O)C=1C(=O)NC(C(=O)OCC)CC1=CC=CC=C1 BPZZWRPHVVDAPT-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 231100000769 Phycotoxin Toxicity 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- BIVJZMRENLVZDT-NVTXSZTESA-N [(1R,2R,3R,7R,9R,10R,12S)-10-acetyloxy-3-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate Chemical compound CC(=O)OC[C@]12[C@H](O)CC(C)=C[C@H]1O[C@@H]1[C@@H](C[C@@]2(C)[C@]11CO1)OC(C)=O BIVJZMRENLVZDT-NVTXSZTESA-N 0.000 description 1
- UIBYXGWICLYODS-UHFFFAOYSA-N [2-(2-methylpent-2-enoylperoxy)-2-oxoethyl] acetate Chemical compound C(C)C=C(C(=O)OOC(COC(C)=O)=O)C UIBYXGWICLYODS-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- DWTTZBARDOXEAM-GXTWGEPZSA-N alpha-Zearalanol Chemical compound O=C1O[C@@H](C)CCC[C@H](O)CCCCCC2=CC(O)=CC(O)=C21 DWTTZBARDOXEAM-GXTWGEPZSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- DWTTZBARDOXEAM-JSGCOSHPSA-N beta-Zearalanol Chemical compound O=C1O[C@@H](C)CCC[C@@H](O)CCCCCC2=CC(O)=CC(O)=C21 DWTTZBARDOXEAM-JSGCOSHPSA-N 0.000 description 1
- DWTTZBARDOXEAM-UHFFFAOYSA-N beta-Zearalanol Natural products O=C1OC(C)CCCC(O)CCCCCC2=CC(O)=CC(O)=C21 DWTTZBARDOXEAM-UHFFFAOYSA-N 0.000 description 1
- FPQFYIAXQDXNOR-PMRAARRBSA-N beta-Zearalenol Chemical compound O=C1O[C@@H](C)CCC[C@@H](O)CCC\C=C\C2=CC(O)=CC(O)=C21 FPQFYIAXQDXNOR-PMRAARRBSA-N 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940054025 carbamate anxiolytics Drugs 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- CXQWRCVTCMQVQX-UHFFFAOYSA-N cis-dihydroquercetin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- VBWIZSYFQSOUFQ-UHFFFAOYSA-N cyclohexanecarbonitrile Chemical compound N#CC1CCCCC1 VBWIZSYFQSOUFQ-UHFFFAOYSA-N 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 150000004478 deoxynivalenol derivatives Chemical class 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000572 ellipsometry Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 229920005684 linear copolymer Polymers 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- DAEYIVCTQUFNTM-ABAIWWIYSA-N ochratoxin B Chemical compound C([C@H](NC(=O)C1=CC=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 DAEYIVCTQUFNTM-ABAIWWIYSA-N 0.000 description 1
- BPZZWRPHVVDAPT-PXAZEXFGSA-N ochratoxin C Chemical compound C([C@@H](C(=O)OCC)NC(=O)C=1C(=C2C(=O)O[C@H](C)CC2=C(Cl)C=1)O)C1=CC=CC=C1 BPZZWRPHVVDAPT-PXAZEXFGSA-N 0.000 description 1
- OSFWJKYWJMZKSM-SCSAIBSYSA-N ochratoxin alpha Chemical compound C1=C(C(O)=O)C(O)=C2C(=O)O[C@H](C)CC2=C1Cl OSFWJKYWJMZKSM-SCSAIBSYSA-N 0.000 description 1
- UXGHWJFURBQKCJ-UHFFFAOYSA-N oct-7-ene-1,2-diol Chemical compound OCC(O)CCCCC=C UXGHWJFURBQKCJ-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009745 pathological pathway Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940070721 polyacrylate Drugs 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000002287 radioligand Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010897 surface acoustic wave method Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229950005720 taleranol Drugs 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 238000012929 ultra trace analysis Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/261—Synthetic macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/268—Polymers created by use of a template, e.g. molecularly imprinted polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/305—Addition of material, later completely removed, e.g. as result of heat treatment, leaching or washing, e.g. for forming pores
- B01J20/3057—Use of a templating or imprinting material ; filling pores of a substrate or matrix followed by the removal of the substrate or matrix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3852—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography using imprinted phases or molecular recognition
Definitions
- the invention relates to a method for binding mycotoxins to a solid carrier.
- DON deoxynivalenol
- ZON zearalenone
- the pathological pathway of DON (12, 13-Epoxy-3a, 7a, 15-trihydroxy-tri- chothec-9-en-8-one) is based on the epoxy group attached to the trichothecen ring (between C12 and C13) and the position and structure of its side groups (Binder et al . 1998).
- ZON is chemically described as [ (-) - (3S, 11E) -3 , 4, 5, 6, 9, 10-Hexahydro-14, 16- dihydroxy-3-methyl-lH-2-benzoxa-cyclotetradecin-l, 7 (8H) -dion] and belongs to the group of resorcyclic acid lactones .
- the standard procedures for the determination of mycotoxins involve discontinuously operated laboratory methods.
- the common scheme for the analysis of mycotoxins is based on an extraction step followed by a time consuming clean-up procedure with a non-polar solvent and subsequent solid-phase extraction using e.g. an immunoaffinity column (Scott et al. 1993; Won-Bo et al. 1997) .
- an immunoaffinity column e.g. an immunoaffinity column
- extracts are then pre-concentrated and finally derivatised for the actual analysis using thin layer chromatography (TLC) , liquid chromatography (LC, HPLC) or gas- chromatographic methods such as GC/MS.
- the method should preferably be robust (i.e. suitable for field testing without the necessity of having a laboratory facility performing such tests or methods) , specific, reliable, re-useable, and useable on an industrial scale.
- the present invention therefore provides a method for binding mycotoxins to a solid carrier, comprising the following steps:
- the present method provides significant advantages, especially with respect to antibodies or antibody-derived solid carriers: the storage stability of the present mycotoxin imprinted polymers exceeds 3 years, whereas antibodies are storeable for 6 month only (as a maximum) . Temperature stability is significantly enhanced with the present polymers, which makes them extremely suitable for industrial methods where high temperature steps (e.g. for pathogen de-contamination) have to be applied.
- the present polymers are by far more resistant to (organic) solvents or against low or high pH (2-11, compared to 5 to 8 for antibodies) .
- the present polymers have also been proven to be easily producible with surprisingly high reproducibility. Automation of the production methods for the present polymers is manageable without much effort - again, in contrast to the difficult up- scaling and automation of antibody-based techniques .
- These developed polymers according to the present invention are suitable as solid phase extraction material for the extraction of the mycotoxin according to the present invention, especially for deoxynivalenol (DON) , 3-acetyl-deoxynivalenol (3-ac-DON) , and zearalenone (ZON) from standard solutions.
- DON deoxynivalenol
- 3-acetyl-deoxynivalenol 3-ac-DON
- ZON zearalenone
- the present polymers may also be re-used 100 times or more (depending on the specific use) for one year or even longer, whereas antibody-based methods may be used only once, at least with the initial quality criteria.
- the present method is superior i.a. with respect to its specificity (i.e. comparable with antibody specificity), simplicity and usability on industrial scale, e.g. for food industry, beverage industry, homeland security, etc..
- the mycotoxin imprinted polymer is specifically imprinted to a template selected from the group comprising calonectrin, deacetylcalonectrin, 7alpha, ⁇ alpha-dihydroxy- calonectrin, 7-hydroxycalonectrin, 8-hydroxy-calonectrin, 3- acetyldeoxy-nevalenol, 15-acetoxydeoxy-nivalenol, 3-acetyl-4, 7- deoxynivalen, 3, 15-diacetyl-deoxynivalenol, 4, 7-dideoxynivalenol, deoxynivalenol, fusarenon-X, nivalenol, diacetylnivalenol, 4-acetyl-scirendiol, diepoxy-diacetyl-scirpenol, 4, 15-diacetyls- cirpendiol, 3, 4-diacety
- the mycotoxin containing solution, suspension or aerosols may be any solution, suspension or aerosol being contactable with an imprinted polymer. Even gas containing preparations with mycotoxins may be regarded as such solutions or suspensions .
- Preferred solutions or suspensions to be contacted with the imprinted polymers according to the present invention are those common in the field of mycotoxin analytics and decontamination. Therefore, these solutions or suspensions are preferably selec- ted from the group comprising field crop preparations, food preparations, water preparations, especially waste water, rinsing water, food processing water, environmental or industrial water samples or in the atmosphere or air samples/aerosols.
- the mycotoxin imprinted polymers are based on functional monomers selected from the group comprising 4- vinylpyridine (4-VP) , methacrylic acid (MAA) , 2-trifluoro- methylacrylic acid (TFM) , methylmethacrylates or other alkyl- methacrylates, alkylacrylates , allyl or arylacrylates and methacrylate, cyanoacrylate, styrene, alpha-methylstyrene, vinylester, especially vinylacetate, vinylchloride, methylv- inylketon, vinylidenchloride, acrylamide, methacrylamid, ac- rylonitril, methacrylonitril, 2-acetamidoacrylic acid, 2-
- the present invention also relates to a method for preparing a mycotoxin imprinted polymer comprising the following steps:
- Protic solvents such as water and methanol have been regarded as hindering polymerisation and disrupting the template-monomer hydrogen-bonding interactions being the prerequisite for providing a suitable imprinted polymer (Norrl ⁇ w et al, 1984) .
- Wulff and co-workers developed polymerisable derivatives of the template molecule, which are co-polymerised with a cross-linking monomer (Wulff, 1995) . These derivatives are obtained by forming covalent bonds between the template and suitable polymerisable monomers . In order to remove the template from the polymer and liberate the binding sites, these covalent bonds have to be chemically cleaved, and are subsequently re-formed during re- binding of the target molecule.
- Mosbach and co-workers have followed a different approach: they rely on the formation of a pre- polymerisation complex between monomers carrying suitable functional groups and the template through non-covalent bonds, such as ionic interactions or hydrogen bonding (Mosbach et al, 1996) . Following polymerisation, the functional groups are held in position by the polymeric network, whereas the template can be simply removed by solvent extraction. The principle means of re- binding the "antigen" to these polymers is again through non-covalent interactions . This self-assembly process is more similar to the natural recognition process, since most biomolecular interactions are non-covalent in nature. In summary, there are following approaches to obtain a molecularly imprinted polymer:
- the template is bound by metal complexation to the monomer/polymer ligands like in Immobilized Metal Affinity Chromatography (IMAC) .
- IMAC Immobilized Metal Affinity Chromatography
- Covalent molecular imprinting The print molecule is coupled to a vinyl monomer by means of a reversible covalent linkage and the derivatised print molecule then copolymerised with an excess amount of cross-linking agent. The print molecule is then cleaved from the imprinted sites using chemical methods. Rebind- ing of the print molecules requires the original reversible bond to reform under conditions that favour substrate uptake. Most chemical linkages in the covalent approach are boronic esters, Schiff bases, and ketals. Binding sites created by covalent binding are characterised by homogeneity in binding strength throughout the whole polymer but have the major disadvantage of slow binding kinetics. In addition, it is not always possible to form covalent bonds between print molecules and functional monomers due to the lack of functionality on the print molecule.
- Non-covalent imprinting is especially preferred according to the present invention.
- the semi-covalent (sacrificial) molecular imprinting In this method developed by Sellergren and Andersson (Sellergren et al, 1990) the template binds covalently e.g. ester bond formation to the functional monomer during imprinting. After the imprinting process the esters are hydrolysed. During the following reaction the acid group of the functional monomer reacts to CO and the alkyl residue. The subsequent rebinding takes place by non-covalent interactions . In general the semi-covalent molecular imprinting approach should combine the homogeneity of binding sites from the covalent approach with the equilibrium of the substrate rebinding from the non-covalent approach.
- Bio-imprinting or protein imprinting utilizes the ability of proteins to form specific binding interactions to an unnatural substrate tailored by a bioimprinting step.
- Conventionally imprinted polymers are highly cross-linked synthetic polymers, usually linear copolymers obtained through ordinary radical polymerisation.
- proteins consist of a primary amino acid sequence forming the ternary structure of globular proteins. Three-dimensional structures are mainly stabilised by concerted, multiple, weak interactions, including hydrogen bonds, ionic forces, and hydrophobic effects.
- a large variety of proteins e.g. subtilisin, a protease, and bovine serum albumin (BSA) were allowed to interact with a template in aqueous solution as reported by Klibanov et al .
- non-covalent molecular imprinting is the preferred method for providing the mycotoxin imprinted polymers according to the present invention.
- the polymers should be rigid enough to preserve the structure of the cavity after removal of the template.
- the polymer should be highly flexible to facilitate equilibrium between release and re-uptake of the template in the cavity.
- accessibility of as many cavities as possible is required as well as high thermal and mechanical stability (macro porous polymers with a high inner surface area) .
- Polymer shrinking in organic or aqueous media should be as low as possible.
- the polymer rigidity can be crucial in the preparation of chromatographic stationary phases and surface layers e.g. for ATR crystals.
- the print molecule or template In general, a print molecule should be soluble in organic solvents and provide suitable functional groups for interaction with the functional monomers, to ensure stable complexation.
- the structure and chemical characteristics of the template usually determines the nature of the imprinting approach.
- Functional monomers are generally selected for strong interactions with the template. So far there is no general protocol or rational design scheme aiding the design of molecularly imprinted polymers (MIPs) . Hence, only empirical knowledge is the starting point for the decision which ingredients should be selected.
- MIPs molecularly imprinted polymers
- Methacrylic acid can provide ionic interactions to basic functional groups within the template. If hydrobhobic interactions are desired, the imprint- ing solvent can be adjusted accordingly to enhance the binding strengths.
- the most widely used functional monomer is methacrylic acid.
- the carboxylic acid group can form hydrogen bonds and serves as proton donor, as well as a hydrogen bond acceptor.
- methacrylic acid interacts ionically with the amine group of templates.
- Polar functionalities like carboxylic acids, car- bamates, carboxylic esters are attracted via hydrogen bonding.
- Methacrylic acid is suitable for templates containing Bronsted basic or hydrogen bonding functional groups close to the stereo- genie center and forms stable cyclic hydrogen bonds with templates containing acid, amide or functionalised nitrogen heterocycles .
- MAA is broadly applicable but not a universal monomer for the generation of high affinity sites.
- 4-Vinylpyridine (4-VP) provides better selectivity for templates containing acid groups due to its basic functionality. Additionally the p-electron system of the 4-VP benzole ring system interacts with positive charges forming ionic bonding. This property makes 4-VP an interesting candidate for MIPs suitable for applications in aqueous environments. In general, a single sort of functional monomer is used in an imprinting protocol . Nevertheless, there have been a number of approaches where combinations of two or more functional monomers, giving ter-poly- mers or higher, have yielded polymers with better recognition abilities than the recognition observed with the corresponding copolymers .
- Cross-linking agent The cross-linking monomer is responsible for mechanical and thermal stability of the polymer. It should be able to sufficiently freeze the pre-polymerisation complex. On the other hand it should release the template after the imprinting process easily and give access to the substrate for rebinding. Hence, template leaking from the polymer is very low and the polymer backbone provides enough micro-, macro- and meso-channels for the substrate to rapidly diffuse to the binding site.
- the cross-linking polymer is another key-factor for the selectivity due to its structure-stabilizing effect on cavities ( ⁇ 10%) . Ethylenegl col dimethacrylate (EDMA) , or tri- methylolpropane trimethacrylate (TRIM) have successfully been used.
- Porogen/solvent The solvent plays a very important role in the generation of molecularly imprinted polymers. Three major characteristics regulate the choice of the solvent to be used: (1) it influences the structure of the MIP extensively. Besides the fact that (2) it has to dissolve template, monomer and cross-linker, (3) the solvent controls the porosity, the polymer morphology and governs the strength of non-covalent interactions.
- Best solvents for molecular imprinting have a very low dielectric constant like toluene or chloroform (i.e. (at 20°C below 40, preferably below 20, especially below 10) .
- MIPs imprinted with non-polar solvents mostly exhibit the best recognition for an analyte.
- Non-polar solvents do not disturb the interaction between template and monomer in contrary to water, which is highly polar. Nevertheless, in most cases the choice of solvent is dependent on the solubility of the print molecule
- the electrostatic interactions of the pre-polymerisation complexes are sensitive to the presence of polar protic solvents. The degree of dissociation of ion-pairs is strongly dependent on the solvent.
- microgel particles are prepared from highly diluted monomer solutions .
- the microgels are composed of intramolecularly crosslinked primary particles formed through multiple crosslinking.
- the physical form of the imprinted polymers changes from phase-separated inhomogeneous blocks to macro- gel particles and finally to discrete microgel particles (Funke et al, 1998) .
- the initiator Polymerisation is generally performed at reaction times between 16 and 48 hours, depending on the batch size and format. A number of different photo- and/or ther- molabile initiators have been used, the most common being 2,2'- azobis- (2, 4-dimethylvaleronitrile) (ABDV) and azobis- (isobutyronitrile) (AIBN) .
- ABDV 2,2'- azobis- (2, 4-dimethylvaleronitrile
- AIBN azobis- (isobutyronitrile)
- the azobisnitriles are decomposed by heat (ABDV: 40°C; AIBN: 60°C) or UV light, resulting in N 2 and two metastable radicals .
- the polymerisation process involves three principal phases: initiation, propagation, and termination. The ability of 0 2 to accept an additional electron from the radicals leads to premature chain-termination.
- the monomer mixture is usually sparged with N 2 or He prior to polymerisation.
- templates with antioxidant properties such as certain phenolic compounds, or molecules with long con- jugated p-electron systems, may act as scavengers to inhibit polymerisation and/or potentially be covalently incorporated in the MIP.
- Electrostatic interactions are anticipated to be mainly responsible for generating the MIP binding sites.
- polymerisation at low temperatures would be beneficial for the imprinting process .
- the separation factor (a) increases with decreasing temperature of polymerisation using AIBN at 0°C.
- Sellergren and Shea observed unchanged selectivity by thermal polymerisation. They also showed that by finishing photo initiated polymerisation with heating (120°C, 24h) higher saturation capacities and improved chromatographic performance is obtained (Sellergren et al, 1993) .
- preferred template:monomer ratios are 1:1 to 100, especially 1:1 to 12; preferred template: crosslinker ratios are 1:1 to 100, especially 1:5 to 20. Even more preferred ratios are 1:5 to 20, especially 1:6 to 12, (template:monomer) and 1:20 to 100, especially 1:30 to 80 (template: crosslinker) .
- Selectivity of the imprinted polymer depends on the orientation of the functional groups inside the cavities and the shape of the cavities . Selectivity increases with the number of binding interactions.
- the template should be extracted after polymerisation under mild conditions and as complete as possible (no leaching) .
- the equilibration with substrate molecules has to be rapid and reversible.
- Non-co- valent imprinting based on acrylic acid requires a fourfold excess of binding sites to ensure good selectivity. Only 15% of the cavities show re-uptake of a template under these conditions; the remaining 85% are irreversibly lost for use in separation, probably because of shrinking of the cavities.
- the design depends on the desired application of the matrix either as HPLC stationary phase (rapid adsorption/desorption: monodisperse spherical particles) or solid-phase extraction (large particles: 50mm: bulk polymerisation and subsequent grinding) .
- HPLC stationary phase rapid adsorption/desorption: monodisperse spherical particles
- solid-phase extraction large particles: 50mm: bulk polymerisation and subsequent grinding
- the binding site distribution is often characterized by a small number of high affinity high selectivity binding sites and a larger class of less selective, low affinity sites. Possible solution therefore is stabilization of the template assemblies, heat treatment of the materials, and selective blocking of the low affinity non-selective sites.
- the column efficiency is of less importance in contrast to the obtainable recovery, the column load capacity, affinity and selectivity.
- MIPs can be prepared in various formats, the most common route is their preparation as bulk polymer with the steps of polymerisation, grinding, sieving, sedimentation and (as described hereinafter as preferred embodiment) :
- Particle formation The polymer is mechanically ground to obtain particles with diameters in the ⁇ m range. The particles are sieved (usually 25-75 ⁇ m mesh size) and sedimented repeatedly from acetone to obtain a uniform particle size. In general, yields around 30-50% of the original bulk MIP are obtained.
- uniform spherical polymer beads can be prepared directly by suspension polymerisation.
- imprinted polymers particles or beads can be rendered magnetic by the inclu- sion of iron oxide, which enables facile removal of the polymer from the solvent .
- the designed MIP has to be tested for its binding capacity of the pre-specified analyte. Usually only 15% of formed cavities can re-bind analyte molecules. Additionally the affinity for the analyte has to be determined (e.g. association constant, dissociation constant) as well as the selectivity for the analyte. There are several ways to determine these parameters . Most common is the characterisation as stationary phase in HPLC. Shift of retention time, peak asymmetry and capacity as well as separation abilities are measured. The application of MIP HPLC columns is also preferred. Molecularly imprinted binding assays using radio-labelled analyte molecules can be more easily applied with all kinds of polymers and various kinds of particle sizes. This test format preferably resembles the format of a conventional ELISA test. Spectrometric detection and immunoassays are rarely used due to sensitivity problems and the lack of availability of antibodies against the analyte, respectively.
- Binding strength and binding-site heterogeneity are of relevance because they are responsible for the peak tailing in HPLC chromatograms making these polymers less favorable for chroma- tographic separations and/or solid-phase extraction applications .
- MIA competitive molecularly imprinted assays
- the present invention provides mycoctoxin MIPS . Therefore mycoc- toxins or structural analogs of mycoctoxins are used as templates.
- Preferred templates are calonectrin, deacetylcalonectrin, 7alpha, ⁇ alpha-dihydroxy-calonectrin, 7-hy- droxycalonetrin, 8-hydroxy-calonectrin, 3-acetyldeoxy-nevalenol, 15-acetoxydeoxy-nivalenol, 3-acetyl-4, 7-deoxynivalen, 3,15-di- acetyl-deoxynivalenol, 4 , 7-dideoxynivalenol , deoxynivalenol, fusarenon-X, nivalenol, diacetylnivalenol, 4-acetyl-scirendiol, diepoxy-diacetyl-scirpenol , 4
- Preferred functional monomers are selected from the group comprising 4-vinylpyridine (4-VP) , methacrylic acid (MAA) , 2-tri- fluoromethylacryic acid (TFM) , methylmethacrylates or other alkylmethacrylates , alkylacrylates , allyl or arylacrylates and methacrylate, cyanoacrylate, styrene, alpha-methylstyrene, vinylester, especially vinylacetate, vinylchloride, methylv- inylketon, vinylidenchloride, acrylamide, methacrylamid, ac- rylonitril, methacrylonitril, 2-acetamidoacrylic acid, 2- (acetoxyacetoxy) ethylmethacrylate 1-acetoxy-1, 3-butadiene, 2- acetoxy-3-butenenitrile, 4-acetoxystyrene, acrolein, acroleindi- ethylace
- the porogenic solvent is preferably selected from the group comprising acetonitrile, methanol, acetone and other apolar solvents, benzene, toluene, chloroform, dichlormethane, tetrahydrofurane, dimethylformamide, dimethyl- sulfoxide, ethanol, 1-propanole, methanol, water or mixtures thereof .
- preferred crosslinkers are selected from the group comprising di-, tri- and tetrafunctional ac- rylates or methacrylates , divinylbenzene (DVB), alkyleneglykols, polyalkyleneglycoldiacrylates und methacrylates, especially ethylenglycoldimethacrylate (EDMA) , trimethyltrimeth-acrylate (TRIM) , or ethylenglycoldiacrylate, vinyl or allylacrylates or methacrylates, diallyldiglycoldicarbonate, diallylmaleate, di- allylfumarat, diallylitaconate, vinylesters, especially divinyloxalate, divinylmalonate, diallylsuccinate, triallyliso- cyanurate, dimethacrylates or diacrylates of bis-ophenol A or ethoxylated bis-phenol A, methylene or polymethylene bisacrylam- ide or bismethayrylamide,
- any suitable polymerisation starters may be used, however, preferably 2,2'- azobis-isobutyronitrile (AIBN), 2 , 2 ' -azobis- (2, 4-dimethylvaler- onitrile) (ABDV) or mixtures thereof are used as starters for said co-polymerisation.
- AIBN 2,2'- azobis-isobutyronitrile
- ABDV 2, 4-dimethylvaler- onitrile
- the co-polymerisation is preferably carried out in an oxygen- free atmosphere.
- the co-polymerisation is started by photoinitiation or by thermal initiation.
- mycotoxin imprinted polymers are provided. It was surprising that with the methods according to the present invention polymers could be provided which exhibit a mycotoxin dRT (retention time difference) value of more than 0,7 thereby showing a satisfactory and specific retention of mycotoxins. Specifically, these polymers are obtainable by a method according to the present invention. With such methods, even mycotoxin dRT values of 1,0 or more, especially of 3,0 or more, are achieved. This was clearly not fo- cusable in the prior art which pointed into the opposite direction (see e.g. Jodlbauer et al . 2002), specifically for molecules having the chemical structure of DON and 2ON or similar chemical structures.
- the preferred specific binding molecules of the polymers according to the present invention are nivalenole, deoxynivalenole, zearalenone, T2 toxin, HT2 toxin, or mixtures thereof, since these are the commercially important ones.
- the examples of the present invention have also specifically designed in view of these preferred mycotoxins, yet without being restricted thereto.
- the specifically preferred functional monomers, 4-vinylpyridine, methacrylic acid, 2-trifluoromethac- rylic acid or mixtures thereof, have been used for building up the polymers .
- Specifically preferred mycotoxins to be imprinted according to the present invention include: (1) trichothecene A und B (12,13- Epoxytrichothec-9-en ring system)M especially HT-2 toxin, Di- acetoxyscirpenol, T-2 Toxin, T-2 Ttetraol, Nivalenol, Deoxynivalenol and Fusarenon-X and (2) all Zearalenone metabolites: Zearalenon, Zeranol, alpha-Zearalanol, Taleranol, beta-Zearalan- ol, alpha-Zearalenol, beta-Zearalenol .
- the mycotoxin imprinted polymers are preferably used for solid phase extraction of mycoctoxins from mycotoxin containing solutions or suspensions, as food additives, for the preparation of a medicament for treating or preventing mycotox- in-caused disorders, for diagnosing the presence of mycotoxins in a tissue sample or fluid sample from humans, from animals or from plants .
- the present polymers may be used in or as biosensors for detecting the presence and/or the amount of mycotoxins in a sample, especially a biological, environmental or industrial sample.
- a preferred use on industrial scale is cleansing of mycotoxin contaminated solutions, suspensions or aerosols.
- Food and beverage analysis and decontamination are preferred fields of use as well as water quality analysis and decontamination, e.g. if poisoned with mycotoxins (homeland security and public security application) .
- Figure 1 Schematic of non-covalent imprinting. (1) self assembly of the print molecule (DON) , functional monomers and cross-linking monomers. After formation of the pre-polymerisation complex (2) the cross-linking monomer polymerises, (3) after extraction of the print molecule, (4) the binding site is free for specific uptake of the substrate.
- DON print molecule
- functional monomers functional monomers
- cross-linking monomers polymerises
- the binding site is free for specific uptake of the substrate.
- FIG. 3 Chromatograms of acetone, 3-acetyl DON, fusarenon-X and DON in (a) the anti-DON MIP column DON-MAA and (b) the blank (control) polymer DON-MAA-BP.
- Stationary phase MAA, EDMA; mobile phase: acetonitrile, flow rate 0.5 ml/min at ⁇ 8 bar backpressure, stainless steel HPLC columns (250 x 4.6 mm id); DON concentration was 1 ⁇ g/ml each.
- Acetone concentration was 10 ⁇ l/ml each.
- FIG. 4 Chromatograms of acetone and ZON on (a) ZON-4VP-BP, (b) ZON-4VP: anti-ZON imprinted polymer (stainless steel HPLC column: 150 x 4.6 mm id), flow rate 0.5 mL/min, mobile phase MeCN, and finally (c) QUE-4VP-BP and (d) QUE-4VP: anti-quercetin imprinted polymer (stainless steel HPLC column: 250 x 4.6 mm id), flow rate 1 ml/min, mobile phase MeCN with 0.1 % HAc. ZON concentration was 0.1 ⁇ g/ml each, acetone concentration was 10 ⁇ l/ml each.
- Mycotoxin MIPs have numerous applications, especially in similar areas of application as conventional antibodies such as Food Analyses (Ramstr ⁇ m et al . , 2001). Due to their higher mechanical and thermal stability, MIPs can be used in applications working in harsh environments. Preferred applications of MIPs are for separation procedures in HPLC columns and solid-phase extraction (SPE) , as recognition matrix in chemical and biosensors, in molecularly imprinted sorbent assays (MIA) similar to a radio-im- muno assays (RIA) and as enzyme mimics.
- SPE solid-phase extraction
- MIA molecularly imprinted sorbent assays
- MIA molecularly imprinted sorbent assays
- RIA radio-im- muno assays
- MIP stationary phases are used for the characterisation of MIPs.
- Retention time is recorded for the imprinted analyte.
- the retention time is compared to structural analogues (ideally a stereoisomer) and should be higher then the used reference.
- the recognition properties of the polymers are then assessed by comparing the retention times (tR) or capacity factors (k') of the template with the structurally related analogues . Following parameters are generally used for the characterisation of MIPs :
- Partition coefficient K describes the ratio of analyte distribution in the mobile phase and the stationary phase.
- the partition coefficient K cannot be directly deduced from the chromatogram.
- tR Total retention time tR: time required for the analytes in the mobile phase to pass through the column (at the peak maximum) .
- tR is a characteristic signature of the analyte, but is influenced by (i) sample load and (ii) mobile phase.
- the sample load is a frequent problem of enantiomer separation: decrease of sample loads leads to an increase in both, retention and selectivity. Furthermore the mass trans fer kinetics are particularly slow in organic mobile phases. This problem is addressed by decreasing the flow rate, (ii) When increasing the aqueous content in the mobile phases polar templates usually become less retained on MIPs, whereas templates of moderate to low polarity become more retained.
- imprinted phases behave more like reversed phases when the aqueous content is high. This leads to pronounced specific binding, frequently in the form of total retention of all hydrophobic compounds, and can be reduced by addition of an organic modifier or a detergent.
- Hold-up time tM time required for an analyte in the mobile phase or mobile phase molecules who do not interact with the stationary phase (not retained; also called void marker) to pass through the column (dead time) .
- Capacity factor k' as quotient of retention time tR and hold-up time tM the capacity factor describes the enhancement of separation by the selective solid phase.
- Preferred techniques are reversed phase, normal phase, ion ex- change, ion suppression and hydrophilic interaction chromatography (for details: see Waters Corporation, 1999)
- MIA Molecularly Imprinted Sorbent Assay
- the present MIPs are specifically suited as non-biological alternatives to antibodies in competitive radiolabelled molecularly imprinted sorbent assays (MIA) .
- MIA molecularly imprinted sorbent assay
- 3H or 14C labelled analyte is used as competitive ligand.
- a molecularly imprinted sorbent assay (MIA) is performed similar to a RIA.
- the bound radiolabelled analyte is detected via a radioactivity detector.
- Binding capacity, selectivity, and affinity can be determined by assays using analogous analytes (see: US patent 6 255 461) . Selectivity in the micromolar range and lowest KD in the low nanomolar range can be observed. Heterogeneity of binding sites can be calculated by saturation studies .
- the assay may also be designed as a competitive fluorescence assay performed with the analyte and an non related fluorescent probe and as an enzyme-linked molecularly imprinted sorbent assay using enzyme labeled substrate as competitive agent in a MIA instead of radio-labeled analytes.
- MISPE Solid-Phase Extraction
- SPE solid-phase extraction
- SPE consists of percolating a known sample volume of a liquid sample through a solid sorbent (in the format of a cartridge, column or disk) under carefully selected conditions favouring the preferential absorption of the analyte over the matrix components.
- the analyte of interest is then recovered from the sorbent by elution in a small volume (smaller than the applied sample volume) of an appropriate solvent mixture.
- High enrichment as well as efficient sample clean up can thus be obtained in one-step.
- Multi-purpose SPE matrices can be used for hydro- phobic analytes . The attainable enrichment and clean up depends on:
- Common phases are hydrophobised silica (C8, C18) , styrene- divinylbenzene copolymers (PS-DVB) and graphitised carbon black (GCB) .
- Reversed phase materials are characterized mainly by a high sample load capacity and a wide range of trapped analytes . Disadvantages are their poor selectivity, their narrow pH stability range and limited breakthrough volumes for hydrophilic analytes.
- specificity has heretofore only be accepted to be provided by the development of high affinity SPE matrices based on biological recognition elements like enzymes, antibodies or cells.
- MISPE the washing and elu- tion conditions need to be carefully optimised in terms of ionic strength, pH, and solvent composition. Best results are usually obtained when using the porogenic solvent as wash solvent. Possible disadvantages can be compatibility problems (many of the solvents are not miscible with water) and the drying of MIP cartridges prior to the washing step. Elution of more weakly bound analytes is generally performed by methanol or water. For more strongly bound analytes the same solvents with the addition of small amounts of acids (acetic acid, trifluoroacetic acid) or bases (TEA) are used.
- acids acetic acid, trifluoroacetic acid
- TAA bases
- MIPs molecularly imprinted polymers
- Methacrylate-based imprinted polymers have the affinity and selectivity required to act as recognition elements in a sensing device.
- a signal is generated upon binding of the analyte to the recognition element.
- the transducer then translates this signal into a quantifiable (one or more physicochemical parameters) output signal.
- MIPs are used as the recognition element instead of a biomolecule.
- Electrochemical sensors classified as amperometric, poten- tiometric, conductometric, or field effect transistor-based.
- Mass-sensitive acoustic transducers e.g., surface-acoustic wave oscillator (SAW) , quartz crystal microbalance (QCM) .
- SAW surface-acoustic wave oscillator
- QCM quartz crystal microbalance
- Optical sensors e.g., ellipsometry, surface plasmon resonance (SPR) or infrared evanescent field.
- membranes as components of electrochemical sensors (eg. conductometric detection) .
- an important aspect in the design of a MlP-based sensor is to find an appropriate way of interfacing the polymer with the transducer, since the MIP layer has to be in intimate contact with the transducer surface.
- the polymer can either be synthesized in situ at the transducer surface or the surface can be coated with the preformed polymer.
- Preferred techniques are: electro-polymerisation on conducting surfaces, spin coating and spray coating, sandwich technique, entrapping of nanometer- or micrometer-sized particles into gels or behind a membrane, spin coating of a suspension of MlP-particles in an inert, soluble polymer.
- Methacrylate based polymers are characterized by their rigidity, which is a necessitity for HPLC solid phases, but a dissadvant- age for the formation of thin coatings . Due to the change in volume caused by solvent changes and drying, polyacrylic molecularly imprinted polymers usually crack easily on germanium (Ge) or zincselenide (ZnSe) ATR-crystals .
- Ge germanium
- ZnSe zincselenide
- thin polymer layers can be produced by the sandwich technique with simple laboratory equipment, it has certain limitations. A crucial step in the sandwhich technique is the assembly of ATR crystal, the spacer (inbeneath the polymerisation liquid) and the cover glass.
- the spacer defines the thickness of the generated polymer layer and the cover glass is necessary for the generation of an even surface and the exclusion of oxygen, which would prevent polymerization. If the polymerization is initiated by heat, the glass cover also prevents evaporation of the porogen. Otherwise the polymerization will fail, even if oxygen is excluded by polymerizing under nitrogen gas stream.
- Ratio between functional and cross-linking monomer MAA The ratio between MAA and cross-linker can increase the "softness" and therefore the coating properties of the polymer.
- the stability of the ATR coating is increased e.g. by changing the ratio of MAA: RIM from 1:1 to 2:1) .
- the plasticizer dibutylphtalate was applied.
- the polar groups of dibutylphtalate are interacting with the polar groups of the polymer. Hence, the polymer chains are loosened up and the movement of the polymer chains is facilitated. Softness and stretching of the generated polymer increases .
- ATR-crystal materials are zincselenide or germanium, both materials have been tested as substrate for the formation of MIP layers. Adhesion of poly-acrylate based MIPs to zincselenide was more feasible, because of the high metallic surface of germanium crystals. By optimization of porogen and monomer ratio the generation of even MIP layers was realized.
- MIPs as artificial receptors, could also be employed for the screening of libraries for potential new drugs and enzyme inhibitors.
- the target com- pounds potential mycotoxin mimics
- the target com- pounds can be specifically recognized by the respective MIPs from an entire library.
- Nivalenol, fusarenon-X, 15-acetyl deoxynivalenol, 3- acetyl deoxynivalenol, quercetin, and zearalenone were supplied by Sigma-Aldrich (St. Louis, MO) .
- the molecularly imprinted polymer (IMP) was prepared by bulk polymerisation.
- the molar ratios of the ingredients are listed in Table 1 (DON) and Table 2
- the polymer was then sedimented, in order to eliminate particles ⁇ 5 ⁇ m and for obtaining a uniform particle size.
- the sedimentation was done in -250 mL acetone; after two hours the supernatant solution was discarded and fresh acetone was added to the precipitated MIP particles. The majority of small particles was eliminated after five to six sedimentations .
- the polymer particles were filtrated, washed with methanol and dried at 45°C for 24 hours.
- HPLC analysis The HPLC-analysis was performed using a Dionex HPLC (Dionex, Sunnyvale, CA, USA) with a P580 low pressure mixing pump and an UVD-340S diode array detector with a spectral range from 200 - 600 nm. After complete extraction of the template, each column was equilibrated with the mobile phase (MeCN with HAc) . The elution was performed at ambient temperature and monitored spectro-photometrically at 200 - 450 nm. The flow rate was kept constant at 0.5 - 1 mL min -1 throughout the whole study.
- the aim of this example was the development and characterisation of molecularly imprinted polymers for the mycotoxins DON and ZON.
- the major challenge for this study were the high costs for the targeted template substances.
- only a few molecularly imprinted test polymers have been prepared after careful consideration of the imprinting procedure.
- the isolation of the toxin from fungi cultures was pursued.
- Both templates, DON and ZON, have OH groups as part of their molecular structure (see Figure 2) .
- DON has three different hy- droxyl groups in 3 , 7, and 15 position of the ring system. Whereas the OH-group in position 7 is non-reactive, the other two OH-groups are reactive and are used for coupling spacers to the DON molecule.
- the OH at position 15 is more reactive than at position 3. This reactivity is the reason for the occurrence of 3-acetyl DON and 15-acetyl DON in nature. It is therefore supposed that this two OH-groups being the most probable non-covalent interaction point for complementary functional monomers, such as methyl-methacrylate or 4-vinylpyridine.
- the structure of ZON shows two reactive OH-groups at the main aromatic ring.
- the two carboxyl-groups at the 14 ring are less attractive for hydrogen bonds due to their minor ability forming such bonds and, secondly, because of their less favourable accessibility due to steric hindering and due to the high flexibility of the large 14-ring system.
- acetonitrile is one of the few solvents being able to dissolve the required amount of DON and ZON for the imprinting protocol, mainly because of its high polarity.
- Solubility of ZON in water is only 20 mg/L; it is slightly soluble in toluol ( ⁇ 1 mg/mL) and progressively more soluble in acetonitrile (> 27 mg/mL) , methylenchloride (> 30 mg/mL), methanol, acetone and in aqueous alkali (see also Hidy et al. 1977) . Solubility of DON is even more difficult to handle; only acetonitrile (approx. 20 mg/ml) was found to be suitable (dichlormethane: 7 mg/ml; toluol: 0.4 mg/ml). Table 1 and Table 2 summarize the generated polymers for DON and ZON. Table 2 List of generated anti-ZON molecularly imprinted polymers
- EDMA cross- linking monomer
- deoxynivalenol shows higher retention times than the structural very similar substances 3-acetyl deoxynivalenol, 15-acetyl deoxynivalenol and fusarenon-X.
- both control polymers DON-4VP-BP and DON- MAA-BP
- DON-MAA-BP control polymers
- the retention index is 1.4 times higher than in the control polymer (1.3 in DON-4VP and DON-4VP-BP) .
- Nivalenol -2.22 12.6 0.8 17.44 1.4 0.5 0.6 0.92
- the OH-group in position 7 is non-reactive
- the other two OH-groups are reactive and, therefore, im- portant for the imprinting process. If these OH-groups do not exist, as it is the case in 15-acetyl and 3-acetyl DON, the recognition ability is decreased, explaining the low cross-reactivity to DON.
- DON-4VP-BP and DON-MAA-BP nivalenol shows a higher retention time than DON most likely due to its higher hydrophobicity.
- Imprinting of ZON was approached by conventionally using ZON in a 4-VP / EDMA co-polymer.
- the acetone peak shifts from 2.0 min in the blank polymer (ZON-4VP-BP) to 2.2 min in the imprinted polymer (ZON-4VP)
- the ZON peak shifts from 4.3 min to 5.4 min in the imprinted polymer (ZON-4VP and ZON-4VP-BP) .
- the respective peak (see Figure 4 (a+b) ) is tailed, indicating an imprinting effect: in both, the blank polymer and the MIP, the same ZON concentration has been applied. Results switching to the functional monomer TFM are worse (ZON-TFM and ZON-TFM-BP) .
- ZON has a double bond incorporated in its 15en ring system. During polymerisation this reactive double bond could be responsible for an incorporation of ZON in the subsequent polymerisation process between the functional monomer and the cross-linker. Therefore, the ZON template molecules cannot be eluted from the generated imprinted polymer, thus blocking the binding sites and resulting in a low binding capacity. Another factor adversely influencing successful imprinting can be attributed to the large ring structure. As 3-dimensional simulations of ZON show this ring system is very flexible and will not remain in a defined sterical position during polymerisation. Due to this permanent movement the formation on an exactly fitting binding site is affected during the non- covalent pre-polymerisation step. Thus created binding sites will exhibit significant structural differences, which will decrease binding strength and selectivity of the synthesized MIP matrix.
- Quercetin is a member of the subclass of the flavonols which are secondary metabolites of various plants, contributing to sensory properties, flavour and to the texture of fruits. Electron delo- calisation throughout the whole ring system of quercetin is responsible for the antioxidant activity of quercetin and results from the formation of stable radicals (Russo et al . 2000).
- the anti-quercetin MIP shows high retention of quercetin. Polymers were successfully imprinted against quercetin and some structural analogues like morin. Zearalenone (ZON) is less similar to quercetin than other flavone compounds, hence less selective binding and retardation in an anti-quercetin MIP is expected. With increasing acetic acid concentration, the difference between the imprinted polymer Que-4VP and the blank polymer
- the separation factor a was determined to be 1.64 and is therefore significantly better than the previously generated ZON-4VP polymer using ZON as the template molecule.
- DON For DON: the use of methacrylic acid and 4-Vinylpyridin as functional monomers instead of N,N-diethyl-2-aminoethylmethacrylate (DAEMA) and ethylenglykoldimethacrylate (EDMA) as crosslinker instead of divinylbenzene (DVB) .
- DAEMA N,N-diethyl-2-aminoethylmethacrylate
- EDMA ethylenglykoldimethacrylate
- VB divinylbenzene
- dummy template quercetin instead of zearalenone resulting in an increase of dRT value from 0,7 to 3,4.
- dRT value increase was especially surprising, since up to date only the use of dummy templates from the same family of substances has been described (Matsui et al . , 2000).
- the dummy template is a member of the flavonoide family (quercetin) , which is not related at all to the mycotoxin zearalenone.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Thermal Sciences (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT8372002 | 2002-05-31 | ||
| AT8372002 | 2002-05-31 | ||
| PCT/EP2003/005688 WO2003101580A1 (en) | 2002-05-31 | 2003-05-30 | Solid mycoctoxin carriers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1509302A1 true EP1509302A1 (de) | 2005-03-02 |
Family
ID=29588427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03755958A Withdrawn EP1509302A1 (de) | 2002-05-31 | 2003-05-30 | Feste mykotoxinträger |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1509302A1 (de) |
| AU (1) | AU2003242600A1 (de) |
| WO (1) | WO2003101580A1 (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111303750A (zh) * | 2020-04-16 | 2020-06-19 | 湖南汇田高分子科技有限公司 | 水钻背面水银皮的水性保护涂料、制备方法及应用 |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004036264A2 (en) | 2002-10-16 | 2004-04-29 | Georgia Tech Research Corporation | Polymers, methods of use thereof, and methods of decomposition thereof |
| GB0509275D0 (en) * | 2005-05-06 | 2005-06-15 | Univ Cranfield | Synthetic receptor |
| EP1988993B1 (de) | 2006-02-21 | 2019-04-17 | Mipsalus Aps | Verbesserte herstellung von molekular geprägten polymeren |
| CN100445307C (zh) * | 2006-10-09 | 2008-12-24 | 南开大学 | 离子液体辅助非水解溶胶-凝胶技术制备分子印迹聚合物 |
| GB0702489D0 (en) * | 2007-02-09 | 2007-03-21 | Univ Greenwich | Solid phase extraction of aflatoxins |
| AU2014200349B2 (en) * | 2009-08-27 | 2015-07-23 | Alltech, Inc. | Synthetic mycotoxin adsorbents and methods of making and utilizing the same |
| CA2770343C (en) * | 2009-08-27 | 2015-03-31 | Alltech, Inc. | Synthetic mycotoxin adsorbents and methods of making and utilizing the same |
| ES2427689B2 (es) * | 2012-03-30 | 2014-04-07 | Universidad Complutense De Madrid | Materiales para el reconocimiento selectivo de micotoxinas de Alternaria (alternariol y alternariol monometil éter) |
| US8957164B2 (en) * | 2012-06-04 | 2015-02-17 | The Sherwin-Williams Company | Coating compositions |
| FR3000076B1 (fr) * | 2012-12-21 | 2015-01-16 | Univ Toulon | Polymere a empreinte et procede de preparation |
| EP2783748B1 (de) | 2013-03-27 | 2019-05-08 | Biotage AB | Verwendung eines sorptionsmittels zur extraktion von mykotoxinen |
| CN103524676B (zh) * | 2013-08-26 | 2014-09-17 | 陕西师范大学 | 2-[(6-氧代-6H-苯并[c]色满-3-基)氧基]丙酸整体柱的制备方法及应用 |
| CN103936943B (zh) * | 2014-04-04 | 2016-05-25 | 江苏大学 | 一种改性高岭土表面印迹聚合物的制备方法及其应用 |
| DE102014008135A1 (de) * | 2014-06-06 | 2015-12-17 | Gfl Gesellschaft Für Lebensmittel-Forschung Mbh | Verfahren zur analytischen Authentizitätprüfung von Inhaltsstoffen in Lebensmitteln unter Verwendung künstlicher Antikörper |
| CN105301147A (zh) * | 2014-06-17 | 2016-02-03 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种液质联用法检测液态乳中己烯雌酚类激素的方法 |
| CN104109216B (zh) * | 2014-07-04 | 2016-05-11 | 山东大学 | 多氢键三聚氰胺核壳分子印迹聚合物及其制备方法 |
| RU2705210C2 (ru) * | 2015-02-04 | 2019-11-06 | Олтек, Инк. | Шаблоны афлатоксина, полимеры с молекулярными отпечатками и способы их получения и применения |
| US20160221983A1 (en) | 2015-02-04 | 2016-08-04 | Alltech, Inc. | Aflatoxin templates, molecularly imprinted polymers, and methods of making and using the same |
| CN104931627B (zh) * | 2015-05-18 | 2016-08-24 | 上海市农业科学院 | 一种固相萃取柱及其应用 |
| CN105372319B (zh) * | 2015-10-15 | 2016-08-24 | 济南大学 | 一种基于银杂化的二氧化锰纳米片构建的黄曲霉毒素b1传感器的制备方法及应用 |
| CN105732890B (zh) * | 2016-04-30 | 2017-07-28 | 中国科学院新疆理化技术研究所 | 一种棉酚分子印迹聚合物的制备方法 |
| CN113008847B (zh) * | 2019-07-23 | 2022-04-15 | 西南交通大学 | 制备喹诺酮类传感液的组合物及方法 |
| CN111551713A (zh) * | 2020-05-15 | 2020-08-18 | 中国科学院过程工程研究所 | 一种covid-19病毒抗体检测微球及其制备方法和含该微球的试剂盒 |
| CN111495432B (zh) * | 2020-06-05 | 2023-05-16 | 深圳职业技术学院 | 聚吡咯/硫化镉印迹复合光催化剂及其制备方法及应用 |
| CN115253697B (zh) * | 2021-04-29 | 2023-12-26 | 天津膜天膜科技股份有限公司 | 高效去除硬度纳滤膜的制备方法 |
| CN113877552A (zh) * | 2021-11-11 | 2022-01-04 | 江南大学 | 一种稻壳基磁性介孔二氧化硅吸附材料及其制备的固相萃取柱 |
| CN114062576B (zh) * | 2021-12-14 | 2023-08-25 | 北京普析通用仪器有限责任公司 | 一种分子印迹静电纺丝纤维膜及其制备方法和微流控芯片及检测玉米赤霉烯酮的方法 |
| CN115684402B (zh) * | 2022-10-25 | 2025-03-25 | 中国检验检疫科学研究院 | 黄曲霉毒素分离电离元件及其制备方法和试剂盒 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT370946B (de) * | 1980-04-23 | 1983-05-10 | Vana Ges M B H | Mykotoxinbindendes gemisch |
-
2003
- 2003-05-30 EP EP03755958A patent/EP1509302A1/de not_active Withdrawn
- 2003-05-30 AU AU2003242600A patent/AU2003242600A1/en not_active Abandoned
- 2003-05-30 WO PCT/EP2003/005688 patent/WO2003101580A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO03101580A1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111303750A (zh) * | 2020-04-16 | 2020-06-19 | 湖南汇田高分子科技有限公司 | 水钻背面水银皮的水性保护涂料、制备方法及应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003242600A1 (en) | 2003-12-19 |
| WO2003101580A1 (en) | 2003-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003101580A1 (en) | Solid mycoctoxin carriers | |
| Dirion et al. | Water-compatible molecularly imprinted polymers obtained via high-throughput synthesis and experimental design | |
| Xu et al. | Molecularly imprinted solid phase extraction coupled to high-performance liquid chromatography for determination of trace dichlorvos residues in vegetables | |
| Haupt | Molecularly imprinted polymers in analytical chemistry | |
| McNiven et al. | Chloramphenicol sensor based on an in situ imprinted polymer | |
| CN101559352B (zh) | 用于检测三聚氰胺的分子印迹聚合物及其制备方法 | |
| Li et al. | Selective recognition of veterinary drugs residues by artificial antibodies designed using a computational approach | |
| Tang et al. | Preparation of molecularly imprinted solid phase extraction using bensulfuron-methyl imprinted polymer and clean-up for the sulfonylurea-herbicides in soybean | |
| Wu et al. | Synthesis of bilirubin imprinted polymer thin film for the continuous detection of bilirubin in an MIP/QCM/FIA system | |
| Andersson et al. | Development of a molecularly imprinted polymer based solid-phase extraction of local anaesthetics from human plasma | |
| Hu et al. | An amobarbital molecularly imprinted microsphere for selective solid-phase extraction of phenobarbital from human urine and medicines and their determination by high-performance liquid chromatography | |
| Feng et al. | A facile molecularly imprinted polymer-based fluorometric assay for detection of histamine | |
| Byun et al. | Selective separation of aspirin using molecularly imprinted polymers | |
| Tan et al. | A new assay system for phenacetin using biomimic bulk acoustic wave sensor with a molecularly imprinted polymer coating | |
| Ávila et al. | Supported liquid membrane-modified piezoelectric flow sensor with molecularly imprinted polymer for the determination of vanillin in food samples | |
| CA2560384C (en) | Processable molecularly imprinted polymers | |
| Zougagh et al. | Automatic selective determination of caffeine in coffee and tea samples by using a supported liquid membrane-modified piezoelectric flow sensor with molecularly imprinted polymer | |
| Allender et al. | 6 Molecularly Imprinted Polymers—Preparation, Biomedical Applications and Technical Challenges | |
| Giovannoli et al. | Peptide-based affinity media for solid-phase extraction of ochratoxin A from wine samples: Effect of the solid support on binding properties | |
| Pan et al. | Synthesis and characterization of a molecularly imprinted polymer and its application as SPE enrichment sorbent for determination of trace methimazole in pig samples using HPLC-UV | |
| Kloskowski et al. | Progress in development of molecularly imprinted polymers as sorbents for sample preparation | |
| Wang et al. | Molecularly imprinted solid-phase extraction coupled with gas chromatography for the determination of four chloroacetamide herbicides in soil | |
| Connolly et al. | Evaluation of photografted charged sites within polymer monoliths in capillary columns using contactless conductivity detection | |
| Tan et al. | A piezoelectric biomimetic sensor for aminopyrine with a molecularly imprinted polymer coating | |
| Yuan et al. | Sensitive determination of rose bengal in brown sugar by a molecularly imprinted solid-phase extraction monolithic capillary column coupled with capillary electrophoresis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20041223 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20081010 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20081202 |